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The study of genomes and genetic defects that underlie complex diseases is an 
active research area that raises much public interest. The complete DNA sequence of 
the human genome was published in 2003 and this milestone led to many expecta-
tions. With the knowledge of the human genetic sequence it is anticipated that we 
will gain better understanding of the molecular mechanisms behind development 
and disease and that we will be able to advance medicine by discovering new targets 
for drugs to combat today’s incurable diseases like many types of cancer. Since the 
sequencing of the human genome, numerous other genome projects were started 
and today we have sequence information and map data of over 1000 organisms 
(NCBI database). However, the function of approximately half of all genes in human 
and other vertebrate species is still unknown. Therefore, the functional annotation of 
genome sequences is now the major challenge. Functional annotation of the human 
genome can be supported by loss-of-function (knock-out or knock-down) studies in 
model organisms and by the analysis of mutations (polymorphisms) that associate 
with human disorders. 
This thesis is focused on the investigation of the Mpzl3, a novel gene with un-
known function that was identified through mapping of the rough coat mutation 
in mice. The Mpzl3 gene is a member of the myelin protein zero family that consists 
of proteins containing immunoglobulin domains and with suggested roles related 
to immune function and cell adhesion. Functional studies of the Mpzl3 gene in two 
model organisms, mouse and zebrafish, and investigations of the human orthologue 
by in silico techniques, suggested that the product of this gene plays a role in the im-
mune system and is a potential candidate gene for immune-related hereditary hair 
loss diseases in human.
The rough coat mutation
The rough coat (rc) is a spontaneous recessive mutation in the inbred C57BL/6J 
mouse strain. The mutation was first observed at the Jackson laboratory in 1966 
(Dickie, 1966). Homozygous rc mice (rc/rc) are indistinguishable from there litter-
mates in the first two weeks, but from that time they start to develop a complex phe-
notype with several characteristic features. The most prominent peculiarity that the 
rc/rc mice develop is a cyclic and progressive hair loss starting from the first telogen 
phase in the hair cycle. In addition, they frequently develop spontaneous ulcerated 
wounds in the ventral region of the neck (Cao et al., 2007; Hayashi et al., 2004; Racz 
et al., 2009) (Figure 1). Histopathological examination of the homozygous mutant 
mice showed reduced amounts of extracellular matrix components, enlarged seba-
ceous glands in the skin and follicular atrophy in the ulcerated areas (Hayashi et al., 
2004). The melanocyte pigments in the hair follicles change in color from black to 
light brown. Locally, extensive granulated tissue formations were noted with neu-
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trophilic, mastocytic and lymphoplasmacytic dermatitis (Hayashi et al., 2004). In 
addition to the diversified skin phenotypes, the adult rc/rc mice also show growth 
retardation, abnormal bone structure and lower body weight than controls, with 
differences increasing progressively with age (Hayashi et al., 2004). In the femur 
of the rc/rc mice, lack of Ca2+-derived basophilic material was observed, which 
might correlate with the elevated level of calcium in the blood (Hayashi et al., 2004). 
Histopathological study of different organs pointed to several immune system mal-
functions. For example, in the hepatic sinusoids numerous erythrocytes, lympho-
cytes, polymorphonuclear leukocytes and enlarged Kupffer cells were detected, and 
in the trabeculae of the spleen, numerous macrophages were observed loaded with 
hemosiderin granules (Hayashi et al., 2004). The heart is also affected by this muta-
tion. The cardiac muscle fibers are disoriented, and multifocal myocardial degenera-
tion is also observed. In addition, the pups from homozygotes parents have lower 
survival rates compared with the litter from heterozygous parents. This phenomenon 
is probably due to abnormal maternality behavior of the rc/rc female mice (Hayashi 
et al., 2004).
By positional cloning the mutation in the rough coat mice was mapped to a 246-
kb interval on chromosome 9 (Cao et al., 2007; Chapter 2). A missense mutation 
in this area was identified within a novel open reading frame, predicted to encode 
a protein with a conserved immunoglobulin-like V-type domain. The predicted 
protein showed strong homology to myelin protein zero (MPZ) and myelin protein 
zero-like 2 (MPZL2, also called epithelial V-like antigen) and was therefore named 
MPZL3 (myelin protein zero-like 3) (Cao et al., 2007; Chapter 2). The mutation in 
the rc/rc mice occurred at a highly conserved arginine residue within the conserved 
immunoglobulin domain, thus likely altering the MPZL3 protein function. 
Figure 1 The “rough coat” phenotype in the C57BL/6J mouse strain. (A) Hair loss phenotype of an 
adult rc/rc mouse, (B) Ulcerated skin wounds in the neck of rc/rc mouse
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Figure 2. Structure and functions of IgSF proteins. (A) Structural models of proteins belonging to 
the different Ig sets. C1-set: complex of the human MHC class I glycoprotein hla-a2 and the T-cell 
coreceptor cd8 (PDB entry 1akj); V-set: fv fragment of mouse monoclonal antibody d1.3 (balb/c, igg1, 
k) variant chain l glu81->asp  and chain H LEU312->VAL (PDB entry 1a7n) ; I set: central domain of 
cardiac myosin binding protein C (PDB entry 1gxe); C2 set: structures of an HIV and MHC binding 
fragment from human CD4 as refined in two crystal lattices (PDB entry 1cdh). Structures were im-
ported from the Pfam database. (B) Gene ontology (GO) classification of the Ig domain containing 
proteins. The dataset was downloaded using BioMart service based on the Ensembl 56 database, 
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The Immunoglobulin domain superfamily
Immunoglobulin domain containing proteins belong to one of the largest and 
most diverse protein superfamilies based on domain classification. The immu-
noglobulin domain appeared more than 500 million years ago and the structure can 
be recognized already in primitive organisms like members of the poriferan phylum, 
where it is found in cell-surface-receptor proteins (Buljan and Bateman, 2009). The 
domain structure was first identified as a sequence similarity of approximately 100 
amino acids, repeated in antibody proteins. The number of proteins in the immu-
noglobulin superfamily (IgSF) extended with the evolution from invertebrates to 
vertebrates, in parallel with the evolution of the adaptive immune system (Barclay, 
2003). Later it was discovered that immunoglobulin-like sequences are not unique 
only for antibody proteins, but can be found in an wide variety of proteins that plays 
diverse roles, for example in the immune system, and in neural and muscular proc-
esses (Buljan and Bateman, 2009).
Immunoglobulin superfamily domains contain relatively few highly conserved 
residues and their amino acid sequences are highly diverged, therefore it is possi-
ble that most algorithms underestimate their frequency (Barclay, 2003). The basic 
structure of the domain was identified more than 30 years ago (Davies et al., 1971; 
Poljak et al., 1973). The IgSF domains comprise a β-sandwich structure with seven 
or more antiparallel strands in two sheets (Barclay, 2003; Hutchinson and Thornton, 
1993; Richardson, 1981) (Figure 2A). The average length of a protein domain is ap-
proximately 120 amino acids (Buljan and Bateman, 2009). Based on the amino acid 
sequence, two different types of immunoglobulin (Ig) domains can be distinguished. 
The first is the constant domain, or C-domain (IgC), which is shorter (seven strands) 
and contains several characteristics invariable residues, and the second is the var-
iable-domain or V-domain (IgV), raging from eight, to ten strands.  When more 
proteins were sequenced and shown to be Ig-related, the structures of these pro-
teins were reminiscent of the V-domains and were termed V-set. This term does 
not indicate sequence variability as in the antibodies, just sequence similarity to the 
overall V-set sequences (Barclay, 2003). Later many IgSF domains were found with 
sequence patterns more similar to V-domains but more similar in size to C-domains. 
These were called C2-set and the original C-domains were named C1-set (Barclay, 
2003). Another important set variation that is distinguished among the Ig domains 
is called the Intermediate or I-set domain. The I-set domain has sequence features 
of the V-set, but also has some structural features that were previously found only in 
the constant domains (Harpaz and Chothia, 1994). The different Ig sets have varying 
numbers of strands in each of the β-sheets that form the sandwich (Smith and Xue, 
Homo sapiens genes dataset. GO classification was performed using Panther (Protein ANalysis 
THrough Evolutionary Relationships). 
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1997). Ig domains are often characterized by a conserved disulphide bond that links 
the two beta sheets, however this boundary is not essential for the structure of the 
domain, as an active antibody and many other immunoglobulin domain-contain 
proteins lacking this disulphide have been reported (Barclay, 2003).
The functions of the IgSF proteins vary as much as their sequences (Figure 2B). 
First it was suggested that the proteins with Ig domains play a role in the immune sys-
tem, however later more and more proteins were discovered with different attributes. 
Generally the function of the Ig-like domains is to allow binding reactions, however 
the specific interactions mediated by these domains vary widely (Fraser et al., 2006). 
They can bind small molecules, hormones, or large protein complexes, like muscle 
proteins through homo- or heterophilic interactions (Halaby and Mornon, 1998). 
The binding sites on these domains are located on the surfaces of the sheets or in the 
loops that connect the strands (Fraser et al., 2006). IgSF domains are mostly found 
in association with other IgSF domains on membrane proteins. However, they can 
also be associated with other domain types such as fibronectin type III, C-type lectin 
complement control protein, cytokine receptor domains and rarely EGF domains 
(Barclay, 2003; Korhonen et al., 1992; Letunic et al., 2002). Investigations of the evo-
lution of Ig domains point also to an association with kinase domains in poriferans, 
which might suggest that the ancestral function of the Ig is also related to signaling 
(Buljan and Bateman, 2009).
Proteins with a Myelin Protein Zero Domain  
The Myelin Protein Zero Family is a small protein family in the Protein 
Table 1. The  Myelin P0 protein fingerprint containing proteins in the human genome
The list was harvested from the Ensembl release 56 Sept. 2009 database using BioMart service.
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Knowledgebase (UniProtKB) database. The common features are that all members 
of this family have an Ig V-set domain and possess at least three elements out of 
the characteristic  six-element fingerprint of the Myelin P0 protein (S-[KR]-S-x-
K-[AG]-x-[SA]-E-K-K-[STA]-K.) (Entry: PS00568). Currently, four proteins have 
been assigned to this family: Myelin Protein Zero (MPZ), Myelin protein Zero Like 
1 (MPZL1), Myelin protein Zero Like 2 (MPZL2), and Myelin protein Zero Like 3 
(MPZL3). However, when we investigated the Ensembl release 56 Sept. 2009 Homo 
sapiens database we found altogether 16 proteins that have the Myelin P0 protein fin-
gerprint (Table 1). Investigation of the chromosomal localization of the family shows 
that one gene is located on the chromosome 3, two genes are on chromosome 1 and 
on the X chromosome, and the rest of the genes are spread over chromosomes 11 
and 19 (Table 1). The predicted functions of the members of the family, based on the 
Panther (Protein ANalysis THrough Evolutionary Relationships) classification sys-
tem, are mainly linked to cell adhesion , but several of these proteins are also linked 
to cell signaling, immune system processes, and ectoderm development (Table 2.). 
The classification of proteins according to GO terms allow for fast analyses based on 
experts knowledge of the biological data (Stevens et al., 2000), but such automated in 
silico analysis obviously has limitations, since not all published data are reflected in 
GO term annotations. For example, MPZL2 (EVA1) is annotated as an adhesion mol-
Table 2. GO term classification of the human Myelin P0 domain containing proteins 
GO classification was performed using the Panther (Protein ANalysis THrough Evolutionary 
Relationships) server. The number of Myelin Protein 0 domain related genes that are associated to 
the GO term is indicated, together with the gene symbols. Data are based on the Ensembl release 
56 Sept 2009 database.
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ecule, but it was reported that MPZL2 also plays a role in T cell and thymus develop-
ment (DeMonte et al., 2007). Similarly, AMICA1 is associated with the general GO 
term signal transduction, but deeper investigation shows that this signaling function 
might affect the transmigration of leukocytes through epithelial and endothelial tis-
sue (Moog-Lutz et al., 2003), suggesting that this myelin P0 protein might play a role 
in the  immune system too.
Outline of the thesis
The goal of this thesis is the functional characterization of a novel member of the 
myelin P0 protein family, Mpzl3, which is mutated in mice with the rough coat phe-
notype. To gain understanding of the molecular mechanisms behind the complex 
rough coat phenotype, the defects caused by the mutation and the expression pat-
tern of the affected Mpzl3 gene were studied in detail. In addition, knock-down and 
overexpression studies of the zebrafish homolog of Mpzl3 were performed.
Chapter 1 gives a general introduction about the rough coat mutation, a short de-
scription of the phenotype, and introduces the protein family of the mutated gene. 
Chapter 2 describes the microsatellite marker based mapping strategy used to 
identify the rough coat mutation. It shows that the mutation is mapped to a con-
served residue in the Ig domain of the Mpzl3 gene. Furthermore, it describes the 
expression pattern of the Mpzl3 gene in mouse tissues and the localization of the 
MPZL3 protein in skin sections.
Chapter 3 presents the results of in silico and histopathological analyses of the 
MPZL3 gene in human and points out that this gene is a potential candidate for 
immune-related hereditary hair loss.
Chapter 4 describes the functional analysis of the Mpzl3 protein in zebrafish 
by means of overexpression and morpholino knock-down experiments in embryos. 
The knock-down effect was further investigated at the transcriptome level by micro-
array analysis.
Chapter 5 summarizes and discusses the work of this study. 
Mutation in Mpzl3, a Novel Gene Encoding a Pre-
dicted Adhesion Protein, in the rough coat (rc) 
Mice with Severe Skin and Hair Abnormalities
Chapter 2
This chapter is based on:
Cao T, Racz P, Szauter KM, Groma G, Nakamatsu GY, Fogelgren B, Pankotai E, 




The rough coat (rc), is an autosomal recessive mutation, arose spontaneously in 
C57BL/6J mice. Homozygous rc mice develop severe skin and hair abnormalities, 
including cyclic and progressive hair loss and sebaceous gland hypertrophy. The 
rc locus was previously mapped to Chromosome 9. To elucidate the genetic basis 
underlying the rc phenotype development, we carried out positional cloning and 
mapped the rc locus to a 246-kb interval. We identified a missense mutation within 
a novel open reading frame in the rc/rc mice, which is predicted to encode a cell 
adhesion molecule with the highest homology to Myelin Protein Zero (MPZ) and 
Myelin Protein Zero-like 2 (MPZL2, also called Epithelial V-like Antigen). We there-
fore named this gene Mpzl3 (Myelin Protein Zero-like 3). The mutation in the rc/rc 
mice occurred at a highly conserved residue within the conserved immunoglobu-
lin V-type domain, thus likely altering the MPZL3 protein function. Reverse tran-
scriptase-PCR and Western blot analysis revealed expression of the Mpzl3 gene in 
various adult organs, including the skin. Using indirect immunofluorescence, we 
detected MPZL3 protein in the keratinocytes and sebocytes in the skin. Results from 
this study identified a novel gene encoding a predicted adhesion protein whose mu-
tation in the rc mice likely caused the rc phenotype. 
Introduction
The rough coat (rc) mutation arose spontaneously in the C57BL/6J (B6/J) inbred 
mouse strain at the Jackson Laboratory in 1966 (Dickie, 1966). The rc mutation is 
autosomal recessive. Homozygous rc mice are born with no apparent abnormali-
ties, but display unkempt looking hair coats by weaning age, and develop cyclic and 
progressive hair loss thereafter (Figure 1) (Hayashi et al., 2004). In addition, histo-
logical analysis of skin sections revealed sebaceous gland hypertrophy in the rc/rc 
mice (Figure 2) (Hayashi et al., 2004; Ruvinsky et al., 2002). Both male and female 
homozygous rc mice are fertile (Dickie, 1966), although only about a quarter of the 
pups born to rc/rc females survive (Hayashi et al., 2004). Linkage analysis with DNA 
markers assigned the rc locus to 32.0 centimorgan on Chromosome 9, close to the 
Mpi1 gene (2 recombinants among 107 backcross offspring) (Eicher EM, 1977) at 
57.57 megabase (Mb) (Ensembl Mouse Genome Database v38, released in April 2006, 
www.ensembl.org/Mus_musculus), but the gene mutation remained unknown.
The appearance of rough hair coats in rc/rc mice is similar to matted (ma) mice, 
another strain with a spontaneous mutation (Searle AG, 1957). However, tests for 
allelism through breeding experiments with ma and several other mutant strains 
such as ichthyosis (ic), plucked (pk), fuzzy (fz) and rough (ro) (Dickie, 1966), ab-
normal feet and tail (aft) (Ruvinsky et al., 2002) have all been negative. Interestingly, 
mice homozygous for rough fur (ruf), another spontaneous mutation mapped to 
Chromosome 9, demonstrated similar skin abnormalities with the rc/rc mice, such 
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as the “unkempt” and “wet” appearance and sebaceous gland hypertrophy (Park et 
al., 2001; Sweet HO, 1990). However, allelism has not been tested for rc and ruf, and 
the mutation in ruf mice has not been identified.
A previous study of the rough coat mutation (Hayashi et al., 2004) showed link-
age of the rc locus with two microsatellite markers, D9Mit162 at 49.954 Mb (one re-
combinant among 129 backcross offspring) and D9Mit104 at 65.953 Mb (three recom-
binants among 129 backcross offspring). In this study, to elucidate the genetic basis 
and to better understand the molecular mechanisms of rc phenotype development, 
we carried out positional cloning in backcross mice.
Results
Cyclic and progressive hair loss and sebaceous hypertrophy in the rc/rc 
mice: 
Homozygous rc pups were born with no apparent abnormalities, and developed 
normal hair coats that became plush 7 days after birth, suggesting that the initial hair 
growth (follicular neogenesis) in rc/rc pups was normal. However, by day 14 after 
Figure 1. Gross phenotype of the rc/rc mice (a) Hair loss is apparent on the dorsal trunk of an rc/
rc mouse on day 25 after birth. (b) New hair coat retains the rough coat phenotype, sometimes 
with reduced pigmentation. (c) Hair loss is progressive in older rc/rc mice. (d) In more than 50% of 




birth, the rc/rc pups started to show unkempt-looking hair coats (“rough” coat) and 
a loss of glossiness. By day 18, hair loss became apparent on the dorsal, ventral, and 
lateral trunk. At the next anagen, the dorsal skin became dark and thickened, and 
the new hair coats retained the “rough coat” phenotype. Thereafter, the rc/rc mice 
underwent cyclic hair loss, and hair growth, sometimes showing reduced pigmenta-
tion in the new hair coat (Figure 1). Hair loss was progressive and some older rc/rc 
mice became nearly bald. In addition to hair loss, we observed a high incidence of 
spontaneous and persistent ulcerated lesions on the ventral skin of the neck in rc/
rc mice over 1 year of age (17 of 27, 63%) (Figure 1d). Histological analysis of such 
lesions revealed typical features of chronic wounds, including inflammation in the 
wound bed and hyperplasia of the epidermal keratinocytes at the wound edge (Data 
not shown) 
Scanning electron microscopy showed that rc/rc mice have smooth hair shafts 
compared to wild type mice (Figure 2a and 2b). No breakage of the hair shaft was ob-
served in the rc/rc mice by scanning electron microscopy (Figure 2c and 2d), which 
supports that the hair loss phenotype is the consequence of deattachment of the hair 
bulbs and not due to loss of structural integrity of the hair shafts
We observed severe hypertrophy of the sebaceous glands in the skin sections from 
rc/rc mice at day 16 (Figure 3a and 3b). This observation was confirmed by oil red O 
staining of lipids in the cells of differentiated sebocytes (Figure 3c and 3d). Similar 
observations were made in rc/rc skin and at days 24, 34, and 76 (data not shown). 
Sebaceous gland hypertrophy was a result of sebocytes hyperplasia: there were twice 
as many sebocytes per sebaceous gland in rc/rc mice as in +/rc mice (14.9±2.8 vs. 
Figure 2. Ultrastructural analyses of hair shafts in rc/rc mice. Scanning electron microscopy images 
are shown of pelage hair from a 24 day old rc/rc mouse (b, d) and a wild type mouse (a, c).  Notice 
the smooth hair shaft (d) and abnormal hair bulb (b) from the rc/rc mouse.  The presence of the 
hair bulb in (b) suggests that the hair loss in rc/rc mice is not due to breakage of hair.  The smooth 
hair shafts of rc/rc mice (d) may result from the elevated level of sebum in the sebaceous glands.
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6.2±2.5 in the day 76 samples examined (P<<0.01). The smooth hair shafts observed 
in rc/rc mice (Figure 2) likely are the consequence of increased sebum production by 
the enlarged sebaceous glands.
High-resolution linkage analysis: 
Before this study, no mapping interval was defined for the rc locus, even though 
it had been mapped close to the Mpi1 gene (Eicher EM, 1977) and two microsatel-
lite markers, D9Mit162 and D9Mit104 (Hayashi et al., 2004). To define a mapping 
interval for the rc locus, we outcrossed B6/J-rc/rc mice with both CAST/Ei mice and 
BALB/cJ mice to obtain F1 hybrids (+/rc) on two mixed strain backgrounds to avoid 
a potential low rate of recombination within the rc region (Fernandez-Gonzalez et 
al., 2002). Female F1 hybrids were backcrossed with male B6/J-rc/rc mice to obtain 
F2 hybrids.
We monitored F2 hybrids daily from birth for the rc phenotype development. F2 
hybrids that showed unkempt hair coats by day 16, hair loss by day 24, ensuing hair 
growth, and subsequent hair loss were considered phenotypic and homozygous 
for the rc mutation (rc/rc). F2 hybrids that never showed hair abnormality at these 
stages were considered non-phenotypic and heterozygous for the rc mutation (+/rc). 
Penetrance of the rc phenotype was 100% in both F2 hybrid backgrounds.
Figure 3. Sebaceous gland hypertrophy in the rc/rc mice. (a, b) Hematoxylin and eosin staining 
and (c, d) oil red O staining of lipids in back skin sections from (a, c) a +/rc and (b, d) an rc/rc mouse. 
Arrowheads point to the sebaceous glands. (b, d) Notice the hypertrophic sebaceous glands in the 
rc/rc mouse. The sebocytes (d) in the rc/rc mouse are functional lipid-secreting cells as (c) in the 
normal mouse. Bar = 100 mm
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We analyzed linkage between the rc locus and five microsatellite markers in 200 
B6/J-BALB/cJ F2 hybrids (Table 1). Linkage was shown between the rc locus and all 
five microsatellite markers (p<<0.0001). All four recombinants with D9Mit191 also 
showed recombination with D9Mit162 and D9Mit73, and none of them showed re-
combination with D9Mit67 or D9Mit328. All six recombinants with D9Mit328 also 
showed recombination with D9Mit67, and none of them showed recombination with 
D9Mit73, D9Mit162 or D9Mit191. These recombinations defined the rc interval be-
tween D9Mit328 and D9Mit191.
Using a similar approach, we analyzed linkage between the rc locus and the pub-
lished polymorphic microsatellites shown in Figure 4a in 361 B6/J-CAST/Ei F2 hy-
brids. We were able to reduce the rc interval to 1.560 Mb, between D9Mit228 and 
D9Mit192. We then identified eight novel microsatellite polymorphisms within the 
D9Mit228~D9Mit192 interval between B6/J and CAST/Ei strains (Figure 4a). The 
chromosomal locations and primer sequences of these novel polymorphisms are 
shown in Table 2. Haplotype analysis of F2 hybrids B292, B329 and B359 revealed that 
the rc locus lay within a 246-kb interval, between 44.8334 Mb (microsatellite # 9) and 
45.0796 Mb (microsatellite #25) (Figure 4b).
Mutation detection: 
Within this 246-kb interval, there are 10 candidate genes, including nine known 
genes and one novel gene (Figure 4c). Using reverse transcriptase (RT)-PCR analy-
ses, we detected expression of nine of the 10 candidate genes in normal as a well 
as rc/rc skin (data not shown). As we could not pinpoint a most likely “functional” 
candidate gene, such as one whose expression in the rc/rc skin was drastically down-
regulated, we carried out sequence analyses of all the coding sequences and flanking 
splice sites of all 10 candidate genes. There are total of 71 exons among these genes, 
68 of which contain coding sequences, according to the Ensembl Mouse Genome 
Database (www.ensembl.org/Mus_musculus). These numbers included all exons 
predicted from different transcripts in the Ensembl database (www.ensembl.org/
Table 1. Summary of linkage analysis of five microsatellite marker and the rc locus in 200 
C57BL/6J-BALB/cJ F2 offspring. p<<0.0001 for all markers.
Mb: megabase. The Mb positions are based on the Ensembl Mouse Genome Database (http://
www.ensembl.org/Mus_musculus), v38 (released in April 2006), based on the NCBI m35 assembly 
(released in December 2005). cM: centimorgan.
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Mus_musculus, NCBI m35 assembly released in December 2005, with reference to 
NCBI m36 assembly released in April 2006). We did not identify any mutation in the 
known genes in the rc/rc DNA. 
However, we identified a point mutation in the open reading frame within 
the novel gene ENSMUSG00000070305, located at 44.989~45.009 Mb (Figure 
5, Table 3). This novel gene consists of six exons, and encodes a polypeptide, 
ENSMUSP00000091378, of 230 amino acids. A closer examination revealed 
that the coding sequence did not start with an ATG nor ended with a STOP co-
don. We therefore considered it incomplete.  This novel gene has a human homo-
logue ENSG00000160588 at 117,602,619 ~ 117,628,245 bp on Chromosome 11, and 
a rat homologue ENSRNOESTG00000015598 at 48,004,303 ~ 48,024,405 bp on 
Chromosome 8. The human homologue and rat homologue encode polypeptides 
of 235 (ENSP00000278949) and 236 (ENSRNOESTP00000021062) amino acids, 
respectively. By comparison with the human and rat homologues and analyses of 
the mouse genomic sequence and expressed sequence tags (ESTs), we predicted ad-
ditional four amino acids at the amino and carboxyl termini of the encoded mouse 
polypeptide. There are additional four amino acids at the amino terminus, starting 
with a methionine encoded by ATG. We also identified  an in-frame STOP codon 36 
bp upstream from this ATG within the 5’ flanking sequence. Furthermore we pre-
dicted an additional three amino acids at the carboxyl terminus, followed by a STOP 
Table 2. Summary of linkage analysis of novel microsatellite polymorphisms we identified 
between B6/J and CAST/Ei strains and the rc locus in 361 C57BL/6J-CAST/Ei F2 hybrids.  
Mb: megabase.  The Mb positions are based on the Ensembl Mouse Genome Database (http://
www.ensembl.org/Mus_musculus), v38 (released in April 2006), based on the NCBI m35 assembly 
(released in December 2005).
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codon. Thus, we predicted a polypeptide of 237 amino acids encoded by the mouse 
gene ENSMUSG00000070305. We have submitted this novel gene/mRNA sequence 
to GenBank (GenBank accession number EF102773).
The mutation we identified in the rc/rc DNA is a G→A transition in exon 3 of 
this gene, resulting in an, Arg100→Gln substitution, in the predicted 237-amino acid 
polypeptide (Figure 5). This mutation was confirmed in multiple rc/rc mice of dif-
ferent parents and in rc/+ mice, as well as in C57BL/6J-rc genomic DNA purchased 
from the Jackson Laboratory (Bar Harbor, ME).
To determine whether this mutation could be a polymorphism, we carried out 
Figure 4. High-resolution genetic map of the rc interval and the candidate genes. (a) High-
resolution genetic map of the rc interval based on linkage analysis in 200 C57BL/6J-BALB/cJ and 
361 C57BL/6J-CAST/Ei F2 hybrid offspring. Microsatellite markers in the Ensembl Mouse Genome 
Database (http://www.ensembl.org/Mus_musculus) are shown on the left with their chromosomal 
locations in megabases (Mb). Novel microsatellite polymorphisms between the C57BL/6 and CAST/
Ei strains identified in this study are shown on the right. Marker #10 was concordant with rc in all 
the F2 hybrids we analyzed, and its location relative to the rc locus could not be determined in 
our linkage analysis. (b) Haplotype analysis of the three recombinants with D9Mit191 or marker #3 
among the 361 C57BL/6J-CAST/Ei F2 hybrid offspring. These results show that the rc locus lies with-
in a 246-kb interval. (c) Candidate genes in the 246 kb mapping interval for the rc locus (Ensembl 
Mouse Genome Database, www.ensembl.org/Mus_musculus).
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Figure 5. Gene structure and mutation analysis of a novel gene in which a mutation was identified 
in the rc/rc DNA. (a) Sequence analysis identified a point mutation in a predicted open reading 
frame in the rc/rc genomic DNA, which was confirmed in rc/+ genomic DNA and rc/rc cDNA. We 
have named this gene “Mpzl3” based on the similarity of the predicted domain structure of its 
encoded protein to Myelin Protein Zero (MPZ) and Myelin Protein Zero-like 2 (MPZL2, also called 
EVA1). (b) The Mpzl3 gene (ENSMUSG00000070305), predicted on the basis of multiple Ensembl 
transcripts based on ESTs, in its genomic context. Eva1 (Mpzl2) gene is upstream, and Amica1 gene 
is downstream. (c) Our prediction of the murine Mpzl3 gene that is homologous to the human 
gene ENSG00000160588 and rat gene ENSRNOESTG00000015598. Exon and EST information was 
based on the Ensembl Genome Database (www.ensembl.org) and our prediction by sequence 
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sequence analysis of this gene in multiple mouse strains. This mutation was absent in 
wild type Balb/c, CAST/Ei, B6C3F1 (F1 hybrid of C57BL/6NCr and C3H/HeN MTV-), 
B6D2F1 (F1 hybrid of C57BL/6NCr and DBA/2NCr), CD1, and SwissGP mice.
The protein encoded by the mutated gene: 
According to our prediction based on homology to human and rat counterparts, 
the full length polypeptide encoded by the murine ENSMUSG00000070305 gene 
consists of 237 amino acid residues, and has a predicted molecular weight of 26,058 
Dalton and isoelectric point of 7.73. It is predicted to be a type I transmembrane 
protein, with a signal peptide at the amino terminus (amino acids 1~32), an immu-
noglobulin (Ig)-like V-type domain at amino acids 33~149, and a transmembrane 
domain at amino acids 160~182 (Figure 6). The Ig-like V-type domain is predicted 
to be extracellular upon cleavage of the signal peptide, and the carboxyl terminus 
is predicted to be cytoplasmic. The conserved cysteines in the Ig-like domain are 
at amino acids 53 and 129, and there is a putative N-glycosylation site (NXS/T) at 
amino acid 124. Arg100 is a highly conserved residue within the Ig domain.
Among known murine proteins, the highest sequence homology to this 237-ami-
no acid protein was identified in the Myelin Protein Zero (MPZ) and Myelin Protein 
Zero-like 2 (MPZL2, also called Epithelial V-like Antigen, (EVA1)) (Figure 6). We 
therefore registered this novel gene as Mpzl3 (Myelin Protein Zero-like 3) with the 
International Committee on Standardized Genetic Nomenclature for Mice and the 
Mouse Genomic Nomenclature Committee (MGNC) through the Mouse Genome 
Informatics (MGI) Resource (The Jackson Laboratory, Bar Harbor, ME). Both MPZ 
and MPZL2 (EVA1) proteins have been implicated in cell-cell adhesion (Guttinger et 
al., 1998), and the Ig-like domains in a number of other proteins have been shown to 
mediate homophilic cell-cell adhesion. Hence, it is likely that the MPZL3 protein is 
also involved in cell adhesion through its immunoglobulin V-type domain, and that 
substitution of the highly conserved Arg100 alters its function.
The coding sequence of the six-exon murine Mpzl3 transcript shares an 84.5% 
nucleotide identity with its human homologue, and the murine and human MPZL3 
proteins share an 86.8% identity and 93.2% similarity. However, within the conserved 
Ig-like V-type domain, the murine and human MPZL3 proteins share a 93.3% identity 
and 96.6% similarity. The coding sequence of the six-exon murine Mpzl3 transcript 
shares a 93.3% nucleotide identity with its rat homologue, and the murine and rat 
MPZL3 proteins share a 96.6% identity and 97.9% similarity. Interestingly, EST evi-
comparison between species. Numbers underneath each exon indicate the length of the coding 
sequence in that exon (shaded portion). Exon 2 has 167 bp of coding sequence, and exon 2’ has 
215 bp of coding sequence (48 bp longer than exon 2) as well as a 3’ UTR. Block arrow points to the 
splice site in exon 2’ used to generate the 6-exon transcript. The arrows denote primers 2F, 2R, 4F 
and 4R used for RT-PCR analysis in Figure 6. The asterisk (*) denotes the position of the mutation 
detected in rc/rc DNA. (d) Exon-intron information of the predicted murine Mpzl3 gene.
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dence also suggests a two-exon Mpzl3 transcript in mice (ENSMUST00000035222) 
and rats (ENSRNOT00000032837), encoding a polypeptide of 96 amino acids.  The 
96-amino acid mouse and rat polypeptides are highly homologous, with 90.6% iden-
tity and 95.8% similarity.
A search of the available genome databases showed MPZL3 homologues in hu-
man, chimpanzee, rhesus monkey, rat, mouse, bovine, dog, and opossum. In all of 
these organisms, Arg100 is highly conserved. However, the function of the MPZL3 
protein is not known in any of these organisms.
The murine Mpzl3 gene: 
The murine Mpzl3 gene consists of six exons, spanning over 19 kb on mouse 
Chromosome 9 (44.989 ~ 45.010 Mb) (Ensembl v38; Vega release 18, May 08, 2006) 
(Figure 5b). According to our prediction based on homology to human and rat coun-
terparts, the coding sequences in the murine Mpzl3 exons varied from 30 bp (exon 6) 
to 215 bp (exon 2’), and the introns varied from 1,657 bp (intron 3) to 6,722 bp (intron 
1) (Figure 5c, 5d). EST analysis provided evidence for at least two transcripts through 
alternative splicing, both containing coding sequences flanked by a 5’ UTR that in-
cluded an in-frame STOP codon and a 3’ UTR. One transcript consisted of two ex-
ons encoding a polypeptide of 96 amino acids. EST evidence suggested a 5’ UTR 
of at least 53 bp and a 3’ UTR of at least 3,160 bp for this transcript. This transcript, 
however, does not contain a mutation. Interestingly, there is a consensus splice donor 
site within the coding sequence of exon 2’ (Figure 5d). When this site is used, a tran-
script containing six exons would result from the Mpzl3 gene, encoding a protein of 
237 amino acids. EST evidence suggested a 5’ UTR of at least 57 bp and a 3’ UTR of 
at least 261 bp for this transcript. In the rc/rc mice, the G→A missense mutation we 
identified in exon 3 would result in Arg100→Gln substitution.
Table 3. Sequences of primers used to PCR amplify the six exons of the novel mouse gene 
ENSMUSG00000070305 (later named Mpzl3) for sequence analysis.  
The reverse primer for exon 2/2’ was also used to PCR amplify the two-exon Mpzl3 cDNA 
(primer 2R in Figure 5c).
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Expression of the Mpzl3 mRNA: 
We carried out RT-PCR analysis to determine the tissue distribution of the Mpzl3 
transcripts in normal adult mice. Primers were designed to amplify the complete 
coding sequences from both the six-exon (845 bp amplicon using primers 2F and 
4R) (Figure 5c) and two-exon (457 bp amplicon using primers 2F and 2R) (Figure 
5c) transcripts based on EST predictions. As shown in Figure 7a, the two Mpzl3 tran-
scripts were detected in a variety of organs examined, with high levels of expression 
in the brain, heart, liver, and skin. The tissue distribution patterns of the two-exon 
and six-exon transcripts were similar.
RT-PCR analysis also showed Mpzl3 transcripts expression in the rc/rc mouse 
skin (Figure 7b). We sequenced the RT-PCR products from both normal and rc/rc 
skin complementary DNA (cDNA), and confirmed the G→A mutation in exon 3 of 
Mpzl3 in the rc/rc cDNA derived from the 6-exon transcripts.
To detect the MPZL3 protein, we generated affinity purified rabbit polyclonal 
antibodies against a peptide (DKLTIDWTYRPPSSSRT) in the predicted extracellu-
lar domain of the murine MPZL3 protein. To test the specificity of these antibodies, 
Figure 6. Sequence comparison of the human, murine, and rat MPZL3 protein and murine MPZ 
and MPZL2 (EVA1). The signal peptides and trans-membrane domains are underlined, flanking the 
immunoglobulin (Ig)-like V-type domains, with conserved residues highlighted. “N” over grey back-
ground: N-linked glycosylation site; “C” over grey background: conserved “signature” Cysteines for 
disulfide bond formation in the Ig-like domain. The Arginine (R) 100→glutamine (Q) substitution 
caused by the G→A mutation in the rc/rc mice is highlighted over grey background
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we transfected NIH/3T3 cells with an expression vector encoding a fusion protein 
between the murine MPZL3 and Myc epitope tag. We analyzed total cell extracts 
by western blot analyses using the anti-MPZL3 antibodies, detecting two bands at 
approximately 27 and 29 kDa (Figure 8a). These bands were also recognized by the 
anti-Myc antibody (Figure 8b). The size difference may be due to different post tran-
scriptional modifications. when the anti-MPZL3 antibodies were preabsorbed with 
the DKLTIDWTYRPPSSSRT peptide at a 1:3, 1:10, or 1:32 molar ratio, binding to the 
fusion protein became much weaker at 1:3 molar ratio (Figure 7c; very faint band s at 
27 and 29 kDa were visible with much longer exposure, data not shown) and could 
not be detected at a 1:10 (Figure 8d) or 1:32 molar ratio (data not shown). These result 
suggest that the anti MPZL3 antibodies specific for the antigen. The anti MPZL3 an-
tibodies also detected 27 and 29 kDa bands in NIH/3T3 cells transfected with a plas-
mid encoding the rc mutant MPZL3 protein fused to the Myc tag (data not shown) as 
expected. In addition, using the anti-MPZL3 antibodies, we detected bands that were 
of much higher molecular weight (~80 and ~110kDa), which were not detected with 
preabsorbed anti-MPZL3 antibodies or the anti-Myc antibody (Figure 8a-d). These 
bands could be endogenous MPZL3 with different post-transcriptional modifica-
tions or from different transcripts.
In all the adult mouse organs analyzed by Western blot, we detected a single 
band at approximately 70 kDa (Figure 8e) When we used preabsorbed antibodies to 
analyze skin and kidney extracts, we detected no signal (data not shown) suggesting 
the antibody binding was specific. The band detected is much larger than the size 
predicted from the amino-acid sequence (237 amino acids before the cleavage of pre-
dicted signal peptide), which may result of post-transitional modification, such gly-
cosylation or dimerization or from translation of different transcripts. Interestingly, 
the bands detected in NIH/3T3 cells (~80 and ~110 kDa) were not detected in any 
Figure 7. RT-PCR analysis of Mpzl3 
gene expression. (a) Expression of 
the 6-exon Mpzl3 transcripts (2F-4R) 
and the 2-exon Mpzl3 transcripts (2F-
2R) in normal adult mouse organs. 
The two transcripts had similar tis-
sue distribution. (b) Expression of 
the 6-exon Mpzl3 transcripts (4F-4R 
to amplify exons 3~6) and the 2-exon 
Mpzl3 transcripts (2F-2R) in wild type 
(WT) and rc/rc mouse skin.
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mouse organs analyzed, suggesting they may unique for cultured NIH/3T3 cells.
We were interested to determine MPZL3 protein expression and localization in 
the skin, therefore we carried out indirect immunofluorescence of adult mouse skin 
sections. We detected MPZL3 expression in keratinocytes of the epidermis and hair 
follicles (Figure 9). By examining staining at high magnifications, it was clear that 
the staining was strong around the plasma membrane (Figure 9e and f), consistent 
with the prediction of a transmembrane protein involved in cell adhesion. We also 
detected staining in the cytoplasm, but not in the nuclei. We did not detect differ-
ences in the MPZL3 protein distribution pattern between normal and rc/rc mouse 
skin. Using rc/rc skin sections with hypertrophic sebaceous glands, we also detected 
MPZL3 expression in the sebocytes (Figure 9c, d, and g). As a negative control, indi-
rect immunofluorescence using normal goat serum instead of anti-MPZL3 antibod-
ies did not show any specific staining (data not shown).
Sequence analysis of the Mpzl3 gene in ruf/ruf mice: 
The ruf/ruf mice develop skin abnormalities similar to the rc/rc mice, such as 
“unkempt” and “wet” looking hair coats and sebaceous gland hypertrophy (Park 
et al., 2001), and the locus has been mapped to Chromosome 9 (Sweet HO, 1990). 
Although allelism between these two spontaneous mutations has not been tested 
directly, it is possible that they are caused by mutations in the same gene. However, 
our sequence analysis of the Mpzl3 gene coding sequences did not detect any differ-
Figure 8. Characterization of the anti-MPZL3 antibodies and expression of MPZL3 in adult mouse 
organs. (a–d) Western blot analysis of total cell extracts from control NIH/3T3 cells (lane 1) and 
NIH/3T3 cells transfected with pEF/myc/cyto containing wild-type murine Mpzl3 cDNA (lane 2). 
The primary antibodies used were: (a) rabbit anti-MPZL3 peptide DKLTIDWTYRPPSSSRT affinity-
purified antibodies, (b) mouse anti-Myc tag antibody, rabbit anti-MPZL3 affinity-purified antibod-
ies preabsorbed with (c) 1:3 or (d) 1:10 molar ratio of peptide DKLTIDWTYRPPSSSRT. Blot c showed 
very faint bands of 27 and 29 kDa after a much longer exposure (data not shown). (e) Western blot 
analysis of total protein extracts from adult mouse organs detected by rabbit anti-MPZL3 affinity-
purified antibodies. Sp: spleen; Mu: muscle; Lu: lung; B: brain; Li: liver; T: testis; I: intestine; St: stom-
ach; K: kidney; H: heart; Sk: skin. M: MagicMark XP.
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ence between the parental C3H/HeJ and ruf/ruf genomic DNA purchased from the 
Jackson Laboratory (Bar Harbor, ME).  Therefore, our results suggest that ruf and rc 
are likely not allelic.
Discussion
In this study, we carried out positional cloning of the gene mutated in the rc mice. 
We mapped the rc locus to a 246-kb interval by high-resolution linkage analysis, and 
identified a missense mutation which resulted in an Arg100→Gln substitution in a 
novel open reading frame within this interval. Based on the predicted domain struc-
ture of the encoded protein, we named this novel gene Mpzl3 encoding a full-length 
MPZL3 polypeptide of 237 amino acids.  Arg100 is a highly conserved residue within 
the conserved Ig-like V-type domain. Therefore, substitution of Arg100 is highly 
likely to alter the MPZL3 protein function in the rc/rc mice. 
The MPZL3 protein: 
Through BLAST search, the highest levels of sequence homology with the MPZL3 
protein were identified in the Myelin Protein Zero (MPZ) and MPZL2 (Myelin 
Protein Zero-like 2, also called EVA1) proteins (Figure 6). Within the Ig-like V-type 
Figure 9. Expression of MPZL3 in mouse skin sections detected by indirect immunofluorescence. 
(a–f) MPZL3 (green) was detected in the keratinocytes of the epidermis and hair follicles as well as 
(a–d, g) the sebocytes. (b, d–g) Sections were counterstained with propidium iodide (red). (a, b): 
+/+ skin; (c–g): rc/rc skin. Bar¼50 mm in (a–d), 20 mm in (e–g).
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domain, however, the MPZL3 protein shares a 40.0% identity and 54.2% similarity 
at the amino acid level with MPZ, and a 36.1% identity and 60.5% similarity at the 
amino acid level with EVA1. All the consensus residues within the Ig V-type domain, 
such as the cysteines and the N-glycosylation site, as well as the Arg correspond-
ing to Arg100 in the MPZL3 protein, are conserved between these three proteins. 
Interestingly, the Mpzl3 gene is located approximately 1 kb 3’ to the Eva1 gene, and 
the sizes of exons 2 and 3 are identical (167 bp and 211 bp, respectively). It is possible 
that these two genes arose through tandem duplication.
Whereas the Mpzl3 gene encodes a short peptide of 96 amino acids through an 
alternatively spliced transcript in both mice and rats, there is no EST evidence that 
such a transcript exists in humans. Both the mouse and rat 96-amino acid polypep-
tides possess a signal peptide but have only a portion of the Ig-like domain, and 
lack a transmembrane domain downstream. In addition, EST evidence suggests the 
existence of other forms of Mpzl3 transcripts (Figure 5b). It is not known whether 
such transcripts are expressed at significant levels in mice and rats, and the sub-
cellular location and possible functions of the encoded polypeptides remain to be 
determined.
The rc mutation: 
The rc mutation arose spontaneously without mutagens in 1966, and all the allele 
has been maintained in cryopreserved embryos during most of the past four decades. 
Hence we expected a “simple” mutation without gross chromosomal rearrangement 
(such as those induced by X-ray irradiation). It is therefore not surprising that we 
detect a single nucleotide transition, which resulted in an amino –acid substitution. 
The mutated Mpzl3 transcripts and protein were detected at significant levels in the 
skin of rc/rc mice, suggesting that the effect of the mutation is likely posttransitional. 
Substitution of the highly conserved Arg100 in the conserved Ig-like domain re-
quired for adhesion may result in decreased cell adhesion. Shedding of hair at the 
telogen phase in the rc/rc mice may be one of the effects of such reduced adhesion.
In this study, we did not detect any mutations/polymorphisms in the Mpzl3 gene 
in other mouse strains we analyzed. However, there are at least five documented vari-
ations in the mouse Mpzl3 gene between mouse strains: four of them being synony-
mous, and one being non-synonymous. This non-synonymous polymorphism re-
sults in an Ala27→Val substitution within the signal peptide in the 129X1/SvJ strain, 
and likely has no functional consequence on the mature protein, as the mice appear 
normal.
The abnormalities in the rc/rc mice are not limited to the skin (Hayashi et al., 
2004), and the mutated gene likely plays a role in the normal functioning of multiple 
organ systems. Not surprisingly, the Mpzl3 transcripts were detected in a variety of 
organs. However, no other alleles of the Mpzl3 mutation have been described.  It is 
possible that the mutation we identified in the rc/rc mice is a “hypomorph”. A more 
drastic change in the Mpzl3 gene, such as a large deletion or early frame-shift muta-
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tion, may lead to much more severe abnormalities in other organ systems and result 
in a lethal phenotype, and would therefore have never been documented as a natural 
mutation. Future functional analyses such as knock-out or knock-down experiments 
will be able to address such a possibility. 
Mutations in adhesion molecules: 
Mutations in a number of genes involved in cell adhesion, particularly compo-
nents of the desmosomes, both transmembrane and intracellular, have been associ-
ated with defects of the skin and heart, where there are high levels of mechanical 
stress (McMillan and Shimizu, 2001). The Mpzl3 gene expression was detected at 
high levels in the skin and heart, where the rc/rc mice develop severe abnormalities 
(Hayashi et al., 2004), and the MPZL3 protein is localized to the plasma membrane, 
consistent with the assumption that the MPZL3 protein may be involved in cell adhe-
sion. Whereas there have been no reports of mutations in the MPZL2 (EVA1) gene 
in human diseases, substitutions of conserved residues such as Thr124→Met in the 
Ig domain in the MPZ protein have been identified in patients with Charcot-Marie-
Tooth disease (Chapon et al., 1999; De Jonghe et al., 1999; Misu et al., 2000). Similarly, 
substitution of the highly conserved Arg100 with Gln in the Ig domain of the MPZL3 
protein likely results in alteration of the protein function in the rc/rc mice.
Interestingly, transgenic mice over-expressing c-myc in the keratinocyte stem 
cells also show sebaceous hypertrophy, hair loss, and spontaneous wounds (Arnold 
and Watt, 2001; Frye et al., 2003; Waikel et al., 2001) , though not as severe. In addi-
tion, while the effects of over-expressing c-myc were dominant, the effects of rc mu-
tation were recessive. Over-expression of c-myc has been shown to drive the KSCs 
out of the stem cell compartment (Arnold and Watt, 2001; Waikel et al., 2001), and 
gene expression profiling has revealed that 40% of all down-regulated genes in the 
c-myc transgenic mice encoded cell adhesion molecules or cytoskeleton proteins, 
resulting in the reduced adhesive interactions of KSCs with the local microenviron-
ment or niche. In addition, the failure of hair differentiation of the c-myc transgenic 
mice may reflect an inability of keratinocytes to migrate along the outer root sheath 
to receive hair inductive stimuli (Frye et al., 2003). It is therefore possible that the 
Mpzl3 leads to similarly compromised interactions of the keratinocytes with their 
microenvironment and manifestation of the rc phenotype. 
Materials and methods
Mice: 
All animal procedures were approved by the University of Hawaii Institutional 
Animal Care and Use Committee (IACUC). Mice were maintained in a temperature-, 
humidity-, and light cycle (12:12) controlled vivarium under specific pathogen-free 
conditions. One male and three female heterozygous rough coat (+/rc) mice in the 
C57BL/6J (B6/J) strain background were purchased from the Jackson Laboratory 
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(Bar Harbor, ME) to establish our own rough coat mouse colony. Female BALB/cJ 
and CAST/Ei mice were also purchased from the Jackson Laboratory for backcross 
studies.
Histological analysis: 
The dorsal skin of euthanized B6/J-rc/rc and age- and sex-matched B6/J-+/rc mice 
was shaved, and skin biopsies were collected. They were embedded in OCT or fixed 
in phosphate-buffered formalin and dehydrated and cleared in xylene before being 
embedded in paraffin. The cryosections were stained with oil red O for lipids, and 
the paraffin sections were stained with hematoxylin and eosin. Ultrastructural analy-
ses were made using a Hitachi S-4800 Field Emission Scanning Electron Microscope 
with Oxford INCA X-Act EDS System.
Backcross: 
B6/J-rc/rc mice were outcrossed with both female BALB/cJ and CAST/Ei mice to 
obtain F1 hybrids (+/rc).  Because female rc/rc mice do not breed well (Hayashi et al., 
2004), we used male B6/J-rc/rc mice and F1 females for our backcross experiment to 
obtain F2 hybrids for linkage analysis.
Genotyping: 
Genomic DNA of F2 hybrids was extracted from tail tip biopsy at the time of 
weaning using Proteinase K (Invitrogen Corporation, Carlsbad, CA) digestion and 
ethanol precipitation. PCR reactions were carried out to amplify microsatellites 
polymorphic between the parental strains, and the amplified DNA fragments (am-
plicons) were analyzed using 4% Metaphor agarose (Cambrex, Rockland, ME) gel 
electrophoresis. In cases when there were no more published microsatellite poly-
morphisms between the parental strains in the Mouse Genome Informatics “Strains 
and Polymorphisms” database (www.informatics.jax.org) or the Ensembl Mouse 
Genome Database (www.ensembl.org/Mus_musculus), we designed primers to de-
tect novel polymorphisms between B6/J and BALB/cJ or between B6/J and CAST/
Ei. Microsatellites with at least 15 CA or TG repeats based on sequence information 
in the Ensembl Mouse Genome Database (C57BL/6 strain) were amplified by PCR 
from these strains and the amplicons were analyzed by agarose gel electrophoresis. 
Those with detectable polymorphisms (at least 8 bp on a 4% Metaphor agarose gel) 
were used for linkage analysis.
Linkage analysis:
Backcross offspring were scored for recombination events that segregate the mic-
rosatellite markers contributed by the two parental alleles and the rc locus (indicated 
by the phenotype). The distances between the loci and the LOD scores were calcu-
lated using the QTXb20 software(Manly et al., 2001) .
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Mutation detection:
Primers for sequence analysis were designed based on the C57BL/6 genomic se-
quence and exon structure in the Ensembl Mouse Genome Database (www.ensembl.
org/Mus_musculus). Primers were located in the introns, 5’ and 3’ UTRs or 5’ and 
3’ flanking sequences so that mutations in the exon sequence as well as the splice 
donor, acceptor, and branch sites could be detected. Primers were synthesized at 
Integrated DNA Technologies (Coralville, IA), and PCR reactions were carried out 
using both wild type B6/J and B6/J-rc/rc mouse genomic DNA as templates. The 
amplicons were analyzed by agarose gel electrophoresis, and the DNA was recov-
ered from the gel using GeneClean Spin Kit (Q-Biogene, Carlsbad, CA).  Sequences 
from both strands were obtained BigDye sequencing kit and an ABI PRISM 3100 
Genetic Analyzer (Applied Biosystems, Foster City, CA) at sequencing core facilities 
(MBSR, CGPBRI, and GMBF) at University of Hawaii at Manoa. Once a mutation 
was identified, it was confirmed in four more mice each of both +/+ and rc/rc geno-
types from different parents, and in heterozygous (+/rc) mice. We also confirmed 
the mutation in B6/J-rc genomic DNA purchased from the Jackson Laboratory (Bar 
Harbor, ME) and in PCR-amplified cDNA generated from rc/rc mouse skin RNA. 
Sequence analysis of the mutated gene was also carried out on genomic DNA ex-
tracted from BALB/cJ, CAST/Ei, C3H/HeJ mice (The Jackson Laboratory, Bar Harbor, 
ME), B6C3F1, B6D2F1, CD1, and SwissGP mice (NCI-Frederick Animal Production 
Area, Frederick, MD), and C3H/HeJ-ruf genomic DNA purchased from the Jackson 
Laboratory (Bar Harbor, ME).
RNA extraction and RT-PCR analysis:
The dorsal skin of euthanized B6/J-rc/rc and age- and sex-matched B6/J-+/+ mice 
was shaved, and skin biopsies as well as the internal organs were collected. Samples 
were frozen immediately in liquid nitrogen or immersed in RNAlater (Qiagen, 
Valencia, CA). Total RNA was extracted using TriReagent (Molecular Research 
Center, Inc., Cincinnati, OH) following manufacturer’s manual. Total RNA was re-
verse transcribed using the SuperScript III Reverse Transcriptase Kit (Invitrogen 
Corp., Carlsbad, CA). The first strand cDNA was used as templates for PCR amplifi-
cation.  The quality of the cDNA was confirmed by PCR amplification of glyceralde-
hyde-3-phosphate dehidrogenase cDNA analyzed by agarose gel electrophoresis.
Antibody generation
Two rabbits were immunized with synthesized peptide DKLTIDWTYRPPSSSRT 
(amino acids 63~79, in the predicted extracellular domain of the murine MPZL3 pro-
tein), and the serum was affinity purified for antibodies against the peptide (Bethyl 
Laboratories, Montgomery, TX).
Western blot analysis and indirect immunofluorscence
The full coding sequences of the wild type murine Mpzl3 cDNA, as well as 
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Mpzl3 cDNA harboring the rc mutation, were subcloned into the Pst I/Not I sites 
of pEF/myc/cyto (Invitrogen Corp., Carlsbad, CA), so that the Myc tag was at the 
carboxyl terminus of the fusion protein. The resulting plasmids were transfected 
into NIH/3T3 cells (ATCC, Manassas, VA) using LipofectAmine 2000 (Invitrogen 
Corp.), and the total cellular proteins were extracted using modified RIPA buffer 
(50mM Tris-Cl, pH7.4, 1mM each of EDTA, PMSF, Na3VO4 and NaF, 1% NP-40, 
62.5mM each of ALLN and N-Etylmaleimide, and 1:15 diluted  Protease Inhibitor 
cocktail). Biopsies of adult mouse skin were homogenized and the proteins extracted 
as described (He et al., 2002). Protein extracts were analyzed by gradient (Invitrogen 
Corp.) or non-gradient SDS-PAGE and blotted onto Immobilon transfer membrane 
(Millipore Corporation, Billerica, MA) for Western blot analysis following standard 
protocols. The molecular weight marker used was MagicMark XP (Invitrogen Corp.). 
The rabbit anti-MPZL3 antibodies were diluted 1:400 and mouse anti-Myc tag anti-
body (Covance Research Products, Princeton, NJ) was diluted 1:200. For antibody 
preabsorption, the rabbit anti-MPZL3 antibodies were incubated with excess pep-
tide DKLTIDWTYRPPSSSRT at 1:3, 1:10, or 1:32 molar ratio for 1 hour before being 
added to the blot. Antibody binding was detected with ECL Western Blot Detection 
Reagents (GE Healthcare Bio-Sciences Corp., Piscataway, NJ) and BioMax film 
(Eastman Kodak Company, Rochester, NY). Cryosections of back skin biopsies of 
normal and rc/rc mice were incubated with 1:200 dilutions of rabbit anti-MPZL3 
antibodies or normal goat serum. Antibody binding was detected with goat anti-
rabbit IgG conjugated with FITC, and the slides were mounted in VectorShield with 
propidium iodide (Vector Laboratories, Burlingame, CA). The sections were exam-
ined and photographed on a Zeiss AxioSkop 2 Plus fluorescent microscope or a Zeiss 
5 PASCAL LSM confocal microscope (Carl Zeiss MicroImaging, Inc., Thornwood, 
NY).
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We have recently reported a mutation within the conserved immunoglobulin 
V-type domain of the predicted adhesion protein MPZL3 (MIM 611707) in rough 
coat (rc) mice with severe skin abnormalities and cyclic and progressive hair loss. In 
this study, we analyzed the human orthologue gene MPZL3 on chromosome 11q23.3, 
to test the hypothesis that mutated MPZL3 might be a candidate for similar symp-
toms in humans. Data were integrated from the Ensembl, NCBI and USCS genome 
informatics databases, protein structure modeling was carried out using THMM and 
EBI Inter Pro Scan softwares, domain structure and potential posttranslational mod-
ification sites were identified with CBS servers and 3D structure was generated with 
the Swiss-Model server. Results show that the predicted MPZL3 protein is highly 
conserved in mammals, has two transmembrane motifs flanking an extracellular Ig-
like domain and is expressed in immune cells among others. The R100Q mutation 
identified in rc mice is within the Ig-domain recognition loop known for functions 
in T-cell receptors and cell adhesion. Further support for an immune related role is 
that the homologous Myelin Protein Zero and EVA1 function in cell adhesion and 
immune response. Based on the results of the rc mouse study, 3D structure, homol-
ogy predictions, comprehensive NCBI Entrez database analyses of multiple poly-
morphisms and mutations within the human MPZL3 gene, and its cell and tissue 
expression pattern, we postulate that homologous or compound heterozygous muta-
tions of MPZL3 might be involved in immune mediated human hereditary disorders 
presenting with hair loss.
Introduction 
The rough coat (rc) mutation arose spontaneously (Dickie, 1966) and homozygous 
rc mice show in both sexes growth retardation, cyclic and progressive hair loss, and 
sebaceous gland hypertrophy due to sebocyte hyperplasia which results in increased 
lipid synthesis and clumped hair (rough coat) (Hayashi et al., 2004). In the hepatic 
sinusoids of the liver of rc mice, we noted increased numbers of erythrocytes, lym-
phocytes, polymorphonuclear leukocytes (neutrophils) and enlarged Kupffer cells 
compared to normal controls. By one year of age, 60% of the rc mice develop spon-
taneous and persistent ulcerated lesions on the ventral skin of the neck (Cao et al., 
2007). At the ulcer sites, localized extensive granulation tissue formations were 
present with neutrophilic, mastocytic and lymphoplasmacytic dermatitis (Hayashi 
et al., 2004). The rc locus was previously mapped to 32.0 cM on mouse chromosome 
9 (Eicher EM, 1977). Subsequently, we defined and reduced the mapping interval for 
this locus to 246kb, which contains 11 candidate genes. Using DNA sequence analysis 
of all coding exons and flanking splice sites within this region, we identified a single 
missense mutation in the Myelin Protein Zero Like 3 (Mpzl3) gene (MIM 611707) 
that resulted in an R100Q substitution within the conserved immunoglobulin (Ig) 
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V-type domain of the predicted MPZL3 protein  (Cao et al., 2007) (Chapter 2). In 
this study, towards understanding the normal and pathological function of human 
MPZL3, we analyzed its gene structure along with polymorphisms and mutations, 
tissue expression pattern and functional domains using genome database informa-
tion, homology modeling and protein structure predictions.
Figure 1. Different level of MPZL3 amino acid sequence homologies in mammals and lower verte-
brates. The identical residues (identities) are highlighted with yellow background, the conservative 
substitutions (positives) are highlighted with blue background. Dashes (-) indicate deletions. Bold 
letters show the conserved Immunoglobulin V-type domain. The red highlighted R indicates the 
R100Q mutation found in rc mice. Hs: Homo sapiens, Pt: Pan troglodytes, Mm: Mus musculus, Md: 




Ensembl database analysis identified orthologues of the MPZL3 protein in mam-
mals with 88–99% similarity that declined in non-mammalian vertebrates (Figure 1). 
The R100Q substitution we identified in rc mice lies within the conserved Ig V-type 
domain of MPZL3 and affects a residue conserved in all vertebrate species.
The human gene MPZL3 at chromosome band 11q23.3 is highly homologous to 
the mouse Mpzl3 gene including genomic context, exon/intron organization, nu-
cleotide and predicted amino acid sequences. Analysis of the predicted 235 ami-
no acid MPZL3 protein using TMHMM (Krogh et al., 2001; TMHMM)  and EBI 
InterProScan software revealed two transmembrane motifs at amino acid positions 
12–34 and 159–181 that flank the extracellular Ig-like domain (position 31–148, Figure 
2a). Structural modeling placed the R100Q mutation within the recognition loop of 
the Ig-like domain known for roles in T cell receptors, cell–cell recognition and cell 
Figure 2. (a) MPZL3 domain structure and potential posttranslational modification sites. Empty 
rectangle: signal peptide, yellow hexagons: transmembrane (TmD) domains; purple hexagon: im-
munoglobulin V-type domain; blue triangles: potential N-glycosylation sites; red triangle: potential 
O-glycosylation site; purple arrow, predicted sumoylation site; grey arrows, potential phosphoryla-
tion sites; S: Ser; T: Thr; Y: Tyr. The underlined Y is a predicted sulphated tyrosine. (b) Western blot 
analysis of cultured primary human fibroblasts (donors #9068 and #3980) using affinity-purified 
anti-MPZL3 antibodies (1:500). (c) Immunofluorescent detection of MPZL3 (1:100) in human skin. 
Controls were incubated with normal goat serum instead of anti-MPZL3.
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adhesion (Teichmann and Chothia, 2000). The Human Protein Reference Database 
biological process prediction suggested an immune response role for MPZL3 (Peri, 
2003)
The NCBI Entrez SNP database contained numerous single nucleotide polymor-
phisms (SNPs) within the MPZL3 gene. Two synonymous SNPs fall within the con-
served Ig V-type domain at amino acid positions 63 and 137. A frame shift mutation 
outside the Ig V-type domain is at amino acid 150 -/A. Three non-synonymous muta-
tions, M155V, V168G and V172M substitutions were in exon 4 and a D228V substitu-
tion in exon 6. As the mouse and human genes are orthologues with 84.5% identity 
at the nucleotide and 86.8% identity at the amino acid level that reaches 93.3% within 
the Ig V-type conserved domain (Cao et al., 2007), it is suggested that humans with 
mutations within the conserved Ig V-type domain may develop symptoms similar 
to the rc mouse.
Our RT-PCR studies detected Mpzl3 expression in multiple mouse tissues and 
immunostaining localized MPZL3 in the epidermis and hair follicles (Cao et al., 
2007). Based on EST counts in NCBI, Unigene database human MPZL3 expression 
was similarly detected in brain, esophagus, heart, kidney, liver, lung, muscle, spleen, 
and in addition in blood, colon, eye, lymph node, mammary gland, mouth, ovary, 
parathyroid, pharynx, pituitary gland, prostate, stomach, testis, uterus and vascular 
tissues. EMBL-EBI Array Express microarray database analysis showed MPZL3 ex-
pression in dendritic, CD4 and CD8 central memory and effector T cells.
Western blot analysis of MPZL3 detected a 54 kDa and a fainter 56 kDa band in 
cultured primary human dermal fibroblasts, which may result from dimerization 
and/or from posttranslational modifications of MPZL3 (predicted MW 25.98 kDa, 
Figure 2b). Using immunohistochemistry, we localized MPZL3 in similar regions 
of the human skin (Figure 2c) as in the mouse skin (Cao et al., 2007) including hair 
follicles (not shown).
Conclusion
This study demonstrated that the MPZL3 Ig V-type adhesive domain is extracel-
lular flanked by transmembrane domains, a domain motif found in proteins with 
immune function. Expression of MPZL3 in immune cells supports its potential im-
mune-related role. Furthermore, the evolutionary closely related protein (Ensembl 
Gene Tree View analysis data) Epithelial V-like antigen 1 (EVA1) plays roles in cell 
adhesion and thymus and lymphocyte development (Guttinger et al., 1998). The 
results suggest that the MPZL3 protein may be involved in immune function and 
mutations within the conserved V-type domain may contribute to human disorders 
with immune-system deficiencies.
Significant association exists between mutations causing skin and hair follicle 
abnormalities and immunological defects (Hayashi et al., 2004; Yu et al., 2008). 
Hair follicles have properties of an immune privileged/protected site (Gilhar and 
Chapter 3
38
Kalish, 2006). Human hair loss disorders including alopecia areata, represent a 
breakdown in immune privilege with subsequent destruction of the hair follicle by 
T lymphocytes (Gilhar et al., 2005; Martinez-Mir et al., 2007). Ig-domain containing 
adhesion molecules play important roles in homing of lymphocytes to inflammation 
sites (Gilhar and Kalish, 2006). PVRL1 located on the same chromosome as MPZL3, 
encodes a membrane adhesion protein with one V-like and two C-like extracellular 
Ig domains and is known to be associated with hereditary alopecia (Suzuki et al., 
2000). Alopecia areata affects adults and children of both sexes with a lifetime risk of 
approximately 1.7%. While its exact molecular mechanism is not known, it is consid-
ered an autoimmune disease (Freyschmidt-Paul et al., 2001) and likely a polygenic 
disorder similar to other autoimmune diseases (McDonagh and Tazi-Ahnini, 2002). 
Based on our results, expression and mutational analysis of MPZL3 in patients and 
families may provide valuable information towards understanding the involvement 
of MPZL3 in hereditary alopecia.
Methods
The NCBI (http://www.ncbi.nlm.nih.gov/), Ensembl (http://www.ensembl.org/
index.html), and UCSC Genome Bioinformatics (http://genome.ucsc.edu/) data-
bases were used for gene structure and sequence analyses. EST confirmed protein 
sequence was used to predict the protein structure with TMHMM (Krogh et al., 
2001; TMHMM) (http://www.cbs.dtu.dk/services/TMHMM/) and EBI InterProScan 
softwares (http://www.ebi.ac.uk/InterProScan/). The template sequence that showed 
the highest sequence identity to MPZL3 was 1NEU (Myelin P0 protein precursor) 
and was selected for 3D homology modeling by the 3D jury consensus method 
(Ginalski et al., 2003) using the fold recognition server BioInfoBank Meta Server 
(Metaserver1) (http://bioinfo.pl/meta/). The 3D structure generation was carried out 
through the Swiss-Model server (Guex, 1997) (http://swissmodel.expasy.org//SWISS-
MODEL.html) and visualization was performed using the Swiss-PDBViewer (Guex, 
1997) program (http://expasy.org/spdbv/). MPZL3 domain structure and potential 
posttranslational modification sites identified with EBI-InterProScan (http://www.
ebi.ac.uk/Tools/InterProScan/) and CBS servers (Blom et al., 1999; Gupta R, 2004; 
Julenius et al., 2005), SUMOplot™ Analysis Program (Xue et al., 2006).
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MPZL3 is a novel member of the myelin P0 protein family. The gene was iden-
tified through a mutation in the rough coat mouse strain and is conserved in all 
vertebrates. Although in silico analyses suggest that the gene encodes an adhesion 
molecule with a possible immunological role, functional analyses have not yet been 
reported. In this study we investigated the zebrafish homolog of mpzl3.  We deter-
mined the expression pattern of the gene during zebrafish embryo development by 
whole-mount in situ hybridization, and examined the effects of overexpression and 
morpholino knock-down regulation. Our results show that mpzl3 has an impor-
tant role in early developmental processes, and that its overexpression causes major 
defects in eye development and general retardation of larval development. Knock-
down of mpzl3 using morpholino antisense technology also resulted in several de-
fects, including locomotion disorder, altered head morphology, edema in the eye 
and the heart, and other cardiovascular abnormalities. Microarray analysis of the 
effects of mpzl3 knock-down during early embryogenesis revealed altered expression 
of genes involved in several developmental processes and suggested that mpzl3 might 
be involved in Notch and Wnt signaling. 
Introduction
MPZL3 is a novel member of the myelin P0 family. The gene was identified at 
mouse chromosome 9 (Dickie, 1966), at 44, 86 Mb (Cao et al., 2007) through a spon-
taneous recessive point mutation in an inbred C57BL/6J mouse strain, called rough 
coat (rc) (Cao et al., 2007; Hayashi et al., 2004). The gene encodes a 237 amino acid 
long polypeptide with an Immunoglobulin V-type domain (IgV). The rough coat 
mutation causes a single nucleotide transition in the gene and an Arg-Gln substi-
tution within a conserved residue of the functional IgV domain (Cao et al., 2007). 
RT-PCR analysis revealed that the gene is expressed in a variety of organs like brain, 
esophagus, heart, intestine, kidney, liver, lung, muscle, skin, and spleen (Cao et al., 
2007). The mutated gene in mice causes numerous abnormalities, including growth 
retardation, severe skin abnormalities, myocardial degeneration, hypercalcaemia, 
liver inflammation and abnormal hemosiderin granules deposition in the spleen 
(Hayashi et al., 2004). Although in silico based annotation indicates that the pro-
tein might play a role in thymus and T cell development (Racz et al., 2009), in vivo 
functional analyses have not yet been achieved. Knock-out analysis in mice will be 
a useful approach to study the function of the gene. However, given that the rough 
coat point mutation in Mpzl3 already has strongly effects, it is possible that the com-
plete lack of Mpzl3 function may lead to more drastic changes in the affected organ 
systems and result in a lethal phenotype. Considering the time investment and the 
possible outcome of the mouse knock-out experiment, we decided first to investigate 
the Mpzl3 gene function in the zebrafish embryo model, in which rapid knock-down 
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studies are possible. 
Zebrafish has become a widely used model organism in biology. In the last decade 
many studies have used zebrafish as a model to better understand human diseases or 
to investigate functions of genes conserved between fish and human. The zebrafish 
has several advantages, like easy maintenance, small space requirements, large brood 
size, and reasonably short life cycle (generation time is about 10 weeks). It is a con-
venient model organism to do large scale screenings because the females are able 
to produce 200–300 new progeny every week. As the embryos develop outside the 
mother and remain translucent for several days, it is possible to visually track every 
aspect of their development. The embryogenesis is rapid and most organ systems are 
fully developed by 5 days post-fertilization (dpf). The transparency of the embryos 
can be exploited to localize specific cell types and developing organs by whole mount 
in situ hybridization (WISH) in fixed embryos, or to monitor developmental proc-
esses in real time using fluorochrome tagged cells in living embryos. As the embryos 
are developing ex vivo in the aquarium medium, any soluble molecule can be read-
ily applied and used for example to probe developmental signaling pathways or for 
testing of pharmacological activity. Furthermore, embryo development can be easily 
manipulated by micro-injection of messenger RNAs for overexpression studies or by 
injection of antisense morpholino oligonucleotides for transient gene knock-down. 
The zebrafish embryo model allows the phenotypic assessment of mutations that 
in mammals would cause very early embryonic lethality. For example, even drastic 
cardiovascular defects can be studied, as the embryos can gain sufficient oxygenation 
via diffusion through the skin during the first days of their development (Grillitsch 
et al., 2005; Pelster and Burggren, 1996). 
Relevant to the study of mpzl3, is that the zebrafish immune system has proven 
to be remarkably similar to that of humans (Traver et al., 2003). Studies of hemat-
opoiesis have revealed that most if not all cell types of the human immune system 
have zebrafish counterparts (Berman et al., 2003; Traver et al., 2003). Macrophages 
and neutrophils already develop during the first day of embryogenesis. T cell de-
velopmental genes show strong homologies to mammalian genes with similar ex-
pression and functional profiles. B cells also exist and express activation-induced 
cytidine deaminase but do not undergo class-switch recombination (Barreto et al., 
2005) and somatic hypermutation is inefficient (Wakae et al., 2006). The thymus in 
zebrafish is similar to that of mammals with the main exception that the zebrafish 
thymus remains as two discrete bilateral structures (Meeker and Trede, 2008). T 
cells exit the thymus and populate various tissues including the kidney, pharynx, 
intestinal tract, nose, spleen, and skin. In adult fish the hematopoiesis occurs in the 
kidney which is equivalent to the human bone marrow (Al-Adhami MA, 1977). The 
zebrafish lymphatic system has also been identified (Kuchler et al., 2006; Yaniv et 
al., 2006), although they do not have lymphatic nodes, Peyer’s patches or splenic 
germinal centers. 
In this study we identified the evolutionary conserved counterpart of mamma-
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lian mplz3 in zebrafish and characterized the expression pattern of this gene during 
embryo development. We performed overexpression and morpholino knock-down 
experiments to investigate the function of the mpzl3 gene. In addition to detailed 
phenotype analysis of the fish with enhanced or reduced mpzl3 expression, we used 
microarrays to investigate the global gene expression changes induced by mpzl3 
knock-down.
Results
Characterisation of the mpzl3 gene in zebrafish: 
Based on the Ensembl database (Ensembl release 56 - Sept 2009 Zv8) the ze-
brafish mpzl3 gene (ENSDARG00000079225) is located on chromosome 15 at 47 
Mb on the forward strand. According to the NCBI Reference Sequence database 
(NM_213169.1) the coding sequence of the gene consists of 648 nucleotides and en-
codes a 215 amino acid long polypeptide. We analyzed the protein sequence using the 
InterProScan domain prediction program and identified Myelin P0 motifs at amino 
acid positions 13-37, 62-89, and 91-120, and a conserved Immunoglobulin (Ig) V-set 
domain at amino acid positions 16-99 
Phylogenetic analysis:
To determine the evolutionary relation between the myelin P0 domain (MyP0) 
containing proteins of zebrafish we downloaded all proteins with a MyP0 domain 
using the Ensembl 54 - Danio rerio Zv8 database. This dataset was uploaded into 
the ClustalW multiple sequence alignment program and a phylogenetic tree was 
made using the Neighbor Joining method, allowing the addition of gaps. The results 
(Figure 1) show that Mpzl3 (ENSDARP00000103451) is most closely related to Mpz 
(ENSDARP00000101478; ENSDARP00000056371), Mpzl1 (ENSDARP00000092425) 
and Mpzl2 (ENSDARP00000032601).
Expression of mpzl3 in zebrafish:
To analyze mpzl3 expression during zebrafish development first we carried out 
quantitative RT-PCR (qRT-PCR) analyses using total RNA. As shown in Figure 2A, 
the mpzl3 mRNA levels were highest between the 4-cell and dome stages, probably 
reflecting maternal expression. Expression of mpzl3 dropped to a much lower level at 
80% epiboly, but remained detectable until at least 5 dpf.  For more detailed analyses 
whole-mount in situ experiments were performed to analyze the spatial expression 
pattern of the mpzl3 mRNA at different time points during embryo and larval de-
velopment. We observed that in the early developmental stages (4 cell, 8 cell, and 
30% epiboly) the mRNA was ubiquitously expressed (data not shown). At later time 
points mpzl3 expression became gradually restricted. At 5 dpf, mpzl3 expression was 
specifically detected in different areas of the head, including the anterior neuromasts 
and the branchial arches. We also recognized mpzl3 expression in neuromasts of the 
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posterior lateral line, in the swim bladder, and the cloaca (Figure 2A).
Overexpression analysis of mpzl3:
To investigate the role of mpzl3 in zebrafish we cloned the mpzl3 full length cod-
ing sequence into the pCS2+ plasmid and used SP6 polymerase to transcribe capped 
mRNA for micro-injection into embryos at the 1-2 cell stage. Injection of 5 pg mRNA 
did not induce phenotypic alterations, but injection of 10-75 pg mRNA caused a 
general retardation of development and edema of the heart cavity was sometimes 
observed as well as bent and shortened tails. However, the most remarkable and 
consistent phenotype was aberrant eye development, which was observed in 23% 
of the embryos injected with 10pg of mRNA and 42% of the embryos injected with 
the highest amount of mRNA. Embryos injected with the lowest concentration do 
not show phenotypic difference compare to the uninjected control embryos. Some 
embryos showed aberrant development of both eyes and others showed asymmetric 
development of the two eyes,  with one developing normally and the other being 
highly abnormal or completely undeveloped (Figure3). 
Figure 1. Evolutionary relations of the MyP0 domain proteins of zebrafish. The cladogram was 
made by the ClustalW Neighbour Joining method. 
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Figure 2. Expression of the mpzl3 gene in zebrafish embryos. (A.) qRT-PCR analysis of mpzl3 expres-
sion. Relative expression levels of mpzl3 were determined at the indicated developmental stages 
between the 4-cell stage and 5 dpf. The expression at 80% epiboly is set to 1. Data were normalized 
to expression of peptidylprolyl isomerase A-like (ppial), which showed no changes over the mRNA 
samples used. (B-D). Expression pattern of mpzl3 investigated by whole-mount in situ hybridiza-
tion at 5 dpf. Mpzl3 is highly expressed in the head, including the anterior neuromasts and the 
branchial arches. Furthermore, mplz3 expression was detected in the neuromasts of the posterior 
lateral line, the swim bladder, and the cloaca. Embryos in (B) and (D) are in lateral view, anterior to 
the right. A ventral view of the head is shown in (C), anterior to the top. 
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Morpholino knock-down analysis of mpzl3:
A morpholino knock-down approach was used to block the translation of the 
mpzl3 mRNA during zebrafish embryo development (Figure 4). As controls we used 
non-injected embryos and embryos injected with the standard control morpholino 
from Genetools. The most conspicuous phenotype that we observed was that injec-
Figure 3.  Overexpression analysis of mpzl3. Embryos were injected at the 1-2 cell stage with mpzl3 
capped mRNA. (A) 3 dpf embryo, injected with 10 pg mpzl3 mRNA. The embryo shows cardiac 
edema, a bent tail and only the eye on the right side of the embryo is developed properly. (B) 5 
dpf embryo, injected with 50pg of mpzl3 mRNA, the embryo shows cardiac edema, a shortened 
tail, and only the eye on the left side of the embryo is developed. (C) 3 dpf embryo, injected with 
10 pg of mpzl3 mRNA. Here the embryo shows normal tail development, but neither of the eyes 
was developed. (D) 5dpf embryo, injected with 50 pg of mpzl3 mRNA. Development of the head 
and both eyes was strongly affected. 
Chapter 4
46
tion of 0.25mM morpholino caused 55 % lethality in the injected population. It was 
also notable that after hatching a subset of the embryos (4% of 0.1mM morpholino 
injection, 28% of 0.25mM morpholino injection, and 33% of 0.5mM morpholino 
injection) lost the ability of movement. We punched these morphants with an acu-
puncture needle to force them to move in the liquid medium, but the morphants did 
not react to this treatment. We monitored the phenotype between 3 dpf and 7dpf and 
no changes were observed during this time (data not shown). 
The mpzl3 morphant fish also developed heart edema at 1 dpf. To further examine 
this phenotype we used the fli:EGFP transgenic line which expresses green fluores-
cent protein in the entire vasculatory system. As shown in Figure 4B and 4E-F, the 
structure of the caudal vasculature of the mpzl3 morphants was affected. A possible 
explanation for this observation might be that it is a result of the accumulation of 
erythrocytes in the caudal vasculature region of the morphant fish. We next tested 
whether the cardiovasculatory defects were associated with any alteration of the 
heart rate. Therefore, we investigated the heart rate of 10 mpzl3 morphant fish ver-
sus 10 standard control morphants at 7dpf and calculated the average heart beat per 
minute (bpm). We found that the mpzl3 morphant embryos had a lower heart rate 
compared to the controls (90 bpm vs. 155 bpm). 
Since Mpzl3 proteins have proposed immune functions, we next tested the hy-
pothesis that mpzl3 knock-down might affect thymus and T cell development. To 
this extent we carried out in situ hybridization using the recombination activating 
gene-1 (rag1) thymus specific marker (Corripio-Miyar et al., 2007) and found that 
the mpzl3 morphant fish do not express the rag1 marker at 6 dpf, while rag1 is already 
detectable in wild type zebrafish larvae at 4 dpf (Figure 4C (Willett et al., 1997).
To test the specificity of the morpholino effect, we designed another translation 
blocking morpholino (MO2) upstream of the first morpholino (MO1). Repeating all 
experiments with the second morpholino (MO2), we found that this morpholino 
(MO2) phenocopied the effects of the first morpholino (Figure 4C-D). In addition, 
we used the synthetic mpzl3 mRNA to rescue the morpholino phenotypes by co-
injection. We co-injected in the 1-2 cell stage 116 embryos with 10 pg of the mpzl3 
cRNA and 0.125 mM of the mpzl3-MO2. After the co-injection the survival rate was 
elevated from 45 to 84% at day 5. We investigated the ability of fish to move. After 3 
days all fish were capable of free swimming and responded to needle punching by 
swimming away, while more than 20% of the surviving embryos injected with 0.125 
mM of mpzl3-MO2 showed the motionless phenotype. We also observed that some 
of the embryos co-injected with mpzl3 mRNA and morpholino showed undevel-
oped eye phenotypes (9%) of which more than half also showed heart edema. As eye 
defects and heart edema were also observed in the overexpression analysis, these 
phenotypes are probably due to the effect of increased mpzl3 mRNA level, while the 
increased survival rate and normal motion of the embryos co-injected with mpzl3 
mRNA and morpholino indicates effective rescue of the morpholino knock-down 
phenotype.
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Microarray analysis of the mpzl3 knock-down effect:
To analyze the global gene expression changes that underlie the altered phe-
notypes caused by mpzl3 morpholino knock-down, we carried out 4x44k Agilent 
microarray chip analyses. We investigated the transcriptome level changes in both 
mpzl3-MO1, and mpzl3-MO2 morphant fish at 8 hpf, at which time-point pheno-
typical alterations between morphants and controls could not yet be observed. By 
choosing this early time-point for our analysis we aimed to gain insight into altered 
signaling pathways that might be responsible for the later phenotypic defects. As 
a control we used embryos injected with the standard control morpholino and we 
analyzed the samples in duplicate with a dye swap. Using the Rosetta Resolver pipe-
line for normalization and data analysis, we generated an overlapping dataset of the 
MO1 and MO2 effects versus the standard control. With the significance cut-off at P≤ 
10−4 level we found that 504 sequences associated with 464 genes were up-regulated 
Figure 4. Phenotypes of mpzl3 morphant fish. (A-B) 5 days old wild type (A) and embryo injected 
with 1 nl of 0,25 mM mpzl3 morpholino (MO1) (B). The morphant fish developed heart edema, and 
the erythrocytes often accumulated in the caudal region (black arrowhead). (C,D) Comparison the 
effect of the two translation blocking morpholinos MO1 (C) and MO2 (D). 1 nl of 0.25 mM concen-
tration was injected for both morpholinos. Embryos are shown at 5 dpf. (E-F) Fluorescent micros-
copy images of the caudal vasculature of wild type (E) and  MO1 morphant (F) fli:EGFP fish. In the 
morphant fish it is recognizable that the vasculatory system in the caudal part was affected (white 
arrow) (G-J) whole mount in situ hybridization of wild type (G), standard control morphant (H), and 
mpzl3 MO1 (I) and MO2 (J) morphants with recombination activating gene-1 (rag1) probe at 6 dpf. 
All images show lateral views, anterior to the left.
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(Figure 5A) and 572 sequences associated with 445 genes showed down-regulated 
expression (Figure 5B) with both morpholinos. 
To achieve an unbiased functional annotation of the gene set affected by mpzl3 
morpholino knock-down we performed Gene Ontology (GO) analysis using eGOn 
(explore GeneOntology), a web-based tool for interpreting and statistical analysis of 
genomic data using GO terms (supplementary Table 1 and 2). The eGOn software 
classifies user input gene lists by GO criteria for biological process (GO:0008150), 
cellular components (GO:0005575) and molecular functions (GO:0003674) in a spe-
cies-independent manner, and produces hierarchical trees of GO terms in these three 
categories. Among the up-regulated transcripts we observed gene groups associated 
with negative regulation. For example, we identified negative regulation of cellular 
processes like, negative regulation of cell cycle (GO:0045786), negative regulation of 
the signal transduction (GO:0030514, GO:0030178, GO:0040036, GO:0035023), neg-
ative regulation of endodermal cell fate specification (GO:0042664) and genes which 
play a role in the negative regulation of transcription (her1, tp73l). Genes associated 
with regulation of apoptosis were also identified by GO analysis. Possibly as the con-
sequence of the enhanced expression of the negative regulation processes, a wide 
range of developmental processes were also affected, such as liver (GO:0001889), 
gut (GO:0048547), morphogenesis of the eyes (GO:0048048), skeletal (GO:0001501) 
and muscle development (GO:0007517). Six genes associated with the morphogen-
esis of the epithelium (GO:0002009) showed altered expression. Four out of these 6 
genes, Bloody fingers (blf) Bone morphogenetic protein 2b (bmp2b), GLI-Kruppel 
family member GLI2a (gli2a), Nodal-related 2 (ndr2) showed upregulated expres-
Figure 5. Microarray analysis of the mpzl3 knock-down effect. (A) Venn diagram showing the over-
lap between the probe sequences up-regulated in embryos injected with mpzl3 morpholinos MO1 
and MO2. The 504 sequences overlapping between MO1 and MO2 corresponded to 464 different 
genes. (B) Venn diagram showing the overlap between the probe sequences down-regulated in 
embryos injected with mpzl3 morpholinos MO1 and -MO2. The sequences overlapping between 
MO1 and MO2 corresponded to 445 different genes. The significance cut off level was P≤ 10−4 in 
both cases.
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sion and 2 genes Mix-type homeobox gene 2 (mxtx2) and Siaz-interacting nuclear 
protein (sinup) were down-regulated in the mpzl3 morphants. We also identified 
several genes involved in development of the brain, where we identified specific 
m pzl3 expression by RT-PCR and Western Blot analyses in mouse. Based on the ar-
ray data the expression level of genes involved in forebrain (GO:0030900), hindbrain 
(GO:0030902) midbrain (GO:0030901) and diencephalon (GO:0021536) develop-
ment was increased in mzpl3 morphants. GO investigation of signal transduction 
pathways affected by mpzl3 morpholino knock-down identified eight genes involved 
in Wnt signaling that showed up-regulated expression. These genes included f rizzled 
homolog 8b (fzd8b), dapper homolog 1 (dact1), dickkopf 1 (dkk), and Sp5 transcrip-
tion factor-like (sp5l) frizzled related protein (frzb), frizzled homolog 3 (fzd3), casein 
kinase 2 beta (ck2b) sizzled (szl), which all showed eleveted expression levels in mpzl3 
morphants. Furthermore, we also identified five signaling molecules that play a role 
in the Notch pathway. Four out of these five genes, DeltaD (dld), Hairy-related 6 
(her6), Lunatic fringe homolog (lfng), and zgc136520,(zgc136520) showed up-regu-
lated expression and one gene, disabled homolog 2 (dab2), showed down-regulation. 
In addition, molecules involved in BMP / transforming growth factor beta receptor 
signaling, MAD homolog 1 and 2 (smad1 and smad2) and sizzled (szl), showed up-
regulated expression. 
Discussion
In this study we performed the first functional analysis of mpzl3, a newly identi-
fied myelin P0 family member in zebrafish and the homolog of the gene mutated 
in mice with the rough coat phenotype. Overexpression studies showed that elevat-
ed levels of mpzl3 mRNA strongly affected eye development of zebrafish embryos. 
Knock-down analysis of mpzl3 using morpholinos resulted in lower survival rates, 
cardiovasculatory system defects, and affected locomotion of larvae after hatching. 
Furthermore, expression of the recombination activating gene product (rag1) in the 
thymus was absent in morphant larvae at 6 days postfertilisation. Microarray analy-
sis of the expression pattern changes caused by morpholino knock-down suggested 
that the Wnt and Notch signaling pathways were affected in addition to the expres-
sion levels of several genes involved in developmental processes.
Evolutionary relationships:
Phylogenetic analysis showed that the closest evolutionary related proteins of 
Mpzl3 in zebrafish are Mpz (myelin protein zero), Mpzl1 (myelin protein zero like 1), 
and Mpzl2 (myelin protein zero 2) or Eva1 (epithelial V antigen). All three proteins 
have immunoglobulin V type and myelin P0 domains. Comparing this result to data 
from human and mouse indicates that the members of the family are evolutionary 
conserved.  It is known that EVA1 has the highest sequence homology to MPZL3 
in mice (Cao et al., 2007) and plays a role in thymus and early T cell development 
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(DeMonte et al., 2007; Guttinger et al., 1998). We hypothesized in Chapter 3 that 
EVA1 and MPZL3 might interact with each other (Racz et al., 2009) and this hypoth-
esis has been supported by a recent large-scale extracellular protein interaction study 
called AVEXIS (avidity-based extracellular interaction screening) (Bushell et al., 
2008). In this study, a systematic screen for receptor-ligand pairs within the zebrafish 
immunoglobulin superfamily was performed. Two interacting proteins of Mpzl3 
were identified, including Eva1 and Cssl:d179; however, the interaction strength be-
tween Mpzl3 and Cssl:d179 was one of the weakest measured in this study (Bushell 
et al., 2008). The other closely related protein, Mpz, is known as the major constitu-
ent of the myelin sheath in mammalians, and mutation of Mpz causes hereditary 
motor and sensory neuropathy, called type 1B Charcot-Marie-Tooth disease (CMT). 
CD8-positive T-lymphocytes were present in mpz mutant mice in the endoneurium 
(Schmid et al., 2000; Shy et al., 1997). The number of these immune cells increased 
with time and progression of demyelinating neuropathy, suggesting that the disease 
might be the consequence of autoimmune inflammation (Maurer et al., 2002). 
Mpzl3 expression pattern:
We identified the expression pattern of mpzl3 in zebrafish embryos and larvae 
by whole mount in situ analyses. Expression of mpzl3 in embryos at 5 dpf was found 
to be localized in different areas of the head including the neuromast cells of the 
anterior lateral line and the branchial arches. We also identified specific expression 
in the neuromasts of the posterior lateral line, the swim bladder, and the cloaca. The 
expression in the cloaca is consistent with previous immunohistochemistry results of 
Bushell et al. (2008), who detected Mpzl3 protein in the pronephric duct of embryos 
at 53 hpf. Bushell et al.  also detected Mpzl3 protein in the epidermis. We did not ob-
serve epidermal expression of mpzl3 mRNA in our in situ analysis except for the ex-
pression in epidermal cells of the lateral line neuromasts. The lateral line is an organ 
with hair cells that are involved in reception of mechanical stimuli. It was hypoth-
esized earlier that mpzl3 plays a role during hair morphogenesis (Cao et al., 2007). 
The lateral line organ of zebrafish has been used as a model for hair cell loss and 
regeneration (Ma and Raible, 2009). It is possible that mutation of the protein caused 
abnormal differentiation not only of the hair-follicles cycling in the skin surface, but 
also might affect the sensory ability of the secondary sensory structure. The neuro-
masts are deposited by a migrating primordium that originates from the otic region. 
At the end of zebrafish embryogenesis, this line comprises 7–8 neuromasts regularly 
spaced between the ear and the tip of the tail (Gompel et al., 2001). Adhesion mol-
ecules like cadherins are required for normal lateral line development. For example, 
zebrafish embryos in which cadherin-2 (cdh2) expression had been knocked down 
did not develop an appropriate lateral line (Kerstetter et al., 2004) and cadherin-4 
(cdh4) morphants developed shorter lateral line nerves and a reduced number of 
neuromasts, suggesting a disrupted migration of the lateral line primordium after 
the knock-down of adhesion molecules (Wilson et al., 2007). The signaling process 
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required for normal hair formation and secondary sensory structure involves the 
Notch and Wnt pathways (Hawkins et al., 2007; Ma and Raible, 2009), where we 
observed altered expression in our microarray analysis of mpzl3 morphant fish. In 
addition, we observed that mpzl3 morphant larvae were unable to respond to a touch 
stimulus. The possibility that this phenotype might be due to dysfunction of the lat-
eral line sensory organ requires further investigation.
Overexpression analysis:
The phenotypes caused by overexpression of mpzl3 were variable but the com-
mon phenotypic difference was that the fish developed anophthalmia. The pheno-
type varied between the formation of two very small and immature eyes and asym-
metric eye development, where one eye developed correctly but the other one was 
missing. The processes involved in eye formation are conserved from the planaria to 
the vertebrates (Silver and Rebay, 2005) and require the function of several home-
obox genes like ey/pax6, toy, six3, and six6. Mutation in these genes causes absence 
or ectopic formation of the eyes (Chow et al., 1999; Czerny et al., 1999; Loosli et al., 
1999).  In addition to the conservation of such genes involved in eye morphogenesis, 
several conserved signaling pathways, including the Wnt and Notch pathways that 
were affected upon mplzl3 knock-down, also play a role in eye development (Cagan 
and Ready, 1989; Gage and Zacharias, 2009; Wehrli and Tomlinson, 1998). 
Morpholino knock-down analysis:
Gene knock-down of mpzl3 using two translation blocking morpholinos resulted 
in severe abnormalities in zebrafish embryos, including lower survival rate, immo-
bility, cardiovascular system defects and expression deficiency of the rag1 thymus 
marker. As discussed above, the immobility of mpzl3 morphants in response to touch 
stimuli might be related to dysfunction of neuromast cells that showed mpzl3 expres-
sion in wild type embryos. Two other mechanisms can be hypothesized to explain 
the motionless phenotype. First, as Mpzl3 is protein closely related to Mpz it might 
play a role in myelin sheet formation or have an effect on the transmission/process-
ing of impulses propagated along the myelinated fiber. Second, as Mpzl3 has been 
proposed as an immune-related protein, mutation of the gene might lead to autoim-
mune-derived demyelination of the axons. However, this possibility is perhaps less 
likely since the adaptive immune system is not yet matured in zebrafish embryos. 
Interestingly, when mice heterozygously deficient in mpz were cross-bred with ho-
mozygous null mutants for the recombination activating gene 1 (rag-1) or cross-bred 
with mice deficient in T-cell receptor a-subunit genes (tcra) myelin degeneration 
and impairment of nerve conduction properties was less severe compared to the 
heterozygously mpz-deficient mice without immune cell deficiencies, suggesting that 
T cells are involved in the demyelinating process of hereditary neuropathy caused 
by the mpz mutation (Schmid et al., 2000). Another study demonstrated that mac-
rophages are actively involved in demyelination in a model for  MPZ-caused inher-
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ited neuropathies (Carenini et al., 2001). In addition, CD8-positive T-lymphocytes 
were found in the endoneurium of mpz mutants (Shy et al., 1997). Taken together 
these data provide strong evidence that the immune system plays a role in neuropa-
thies induced by mpz mutation. The possible involvement of mpzl3 in neurodegen-
erative disorders needs to be further studied. In zebrafish a screen was performed for 
mutations that affect myelin gene expression in Schwann cells and oligodendrocytes. 
This screen identified the motionless mutation (mot), associated with the absence of 
the myelin basic protein (Mbp) expression and vascular defects. The mutated fish 
died around 4 dpf probably due to vasculatory system malfunction (Kazakova et al., 
2006).  Another study in zebrafish shows that mutations affecting neurogenesis are 
often associated with cardiovascular defects, like in the natter (nat), viper (vip), otter 
(ott), fullbrain (ful), and snakehead (snk ) mutants (Jiang et al., 1996). In our study of 
mzpl3 morphants, in addition to the motility defect, heart edema was also observed, 
with vasculatory system structure alteration. To investigate the possible relation of 
mpzl3 with the immune system we determined rag1 expression in the morphant em-
bryos. In morphants at 6 dpf obtained with two different mpzl3 morpholinos, no 
rag1 expression could be detected. It is very unlikely that the rag1 deficiency was the 
consequence of a developmental delay, as the control fish showed rag1 expression in 
the thymus at day 4, consistent with the reported rag1 expression pattern (Willett et 
al., 1997). Therefore, the lack of rag1 expression in mpzl3 morphants might be the 
first direct experimental support that the vertebrate Mpzl3 proteins are involved in 
immune system processes. Based on these results, it would be of great interest to 
investigate rag1 expression and T cell functions in the rough coat mutant mice.
Microarray analysis of the mzpl3 knock-down effect:
We performed a preliminary microarray analysis to identify the gene expression 
pattern changes that may underlie the altered phenotypes caused by the mpzl3 mor-
pholino knock-down. To avoid secondary effects of the altered embryo morphology, 
the microarray analysis was performed at 8 hpf, prior to detectable phenotypical dif-
ferences between morphants and controls. Gene ontology term based classification 
of the gene set showing altered expression with both mzpl3 morpholino treatments 
showed that this set included genes involved in developmental processes that were 
affected in embryos with altered mpzl3 expression and/or in the rough coat mice. 
For example, the rough coat mice show severe skin abnormalities and the morphant 
embryos showed up-regulated expression of genes associated with the morphogen-
esis of the epithelium, including blf, bmp2b, gli2a, and ndr2. In addition, ndr2 muta-
tion caused a cyclopia phenotype in zebrafish (Rebagliati et al., 1998), indicating an 
important role of this gene in eye developmental processes, which we found to be 
affected by mzpl3 overexpression. In future work, it would be of interest to extend 
the overexpression study with microarray analysis for comparison with the results 
of morpholino knock-down. Another up-regulated gene linked with developmental 
processes altered in rough coat mice is fibulin 4 (fbln4).  Based on Gene Ontology 
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FBLN4 associated with wound healing and plays a role in elastogenesis as it interacts 
with the propeptide of Lysyl oxidase (LOX), which efficiently promotes assembly of 
LOX onto tropoelastin (Horiguchi et al., 2009). In the mpzl3 mutated rough coat 
mice Lysyl oxidase like molecule (LOXL) was expressed at reduced level (Hayashi et 
al., 2004).  Finally, AP-2 alpha (tfap2a) involved in melanocyte differentiation was 
also up-regulated in the microarray analysis. In rough coat mice melanocyte color 
changes were observed in the hair follicles (Hayashi et al., 2004). 
As we collected our RNA samples for microarray analysis at 8 hpf and the thymus 
developmental processes do not start before 60 hpf (Willett et al., 1999), not surpris-
ingly we found only two differentially expressed genes associated with immune sys-
tem gene ontology terms: sprouty4 (spry4) and interleukin enhancer binding factor 
2 (ilf2), which were upregulated in the morphants. Sprouty 4 is an antagonist of Fgf 
and Ras/Map kinase signaling and has an important role in embryonic develop-
ment (Furthauer et al., 2001). Interleukin enhancer binding factor 2, also known as 
nuclear factor of activated T-cells (NFAT), is one of the several transcription factors 
required for T-cell expression of the interleukin 2 (IL-2) gene. IL-2 is a key cytokine 
for T cell activation  and its absence caused lethal autoimmunity in mice (Ma et al., 
2006), while reduced levels of IL-2 protein caused autoimmune disorders (Crispin 
and Tsokos, 2008; Setoguchi et al., 2005). In zebrafish ilf2 expression was increased 
in regenerating fin tissue following amputation(Yoshinari et al., 2009), but its func-
tion in zebrafish is currently unknown. 
Because the mpzl3 morphant fish developed heart edema and the rough coat mice 
developed cardiac muscle fiber disorientation and multifocal myocardial degenera-
tion (Hayashi et al., 2004), we hypothesized that the expression of genes involved in 
heart developmental processes might be changed in our microarray analysis. Our 
gene set contained four genes related to heart development: DAZ interacting protein 
1 (Dzip1), bone morphogenetic protein 2b (bmp2b) floating head (flh) and nodal-
related 2 (ndr2). Interestingly, bone morphogenetic protein plays a role in heart 
development but together with Hedgehog (Hh) also acts as a negative regulator of 
thymocyte development (Varas et al., 2003).
Finally, the mpzl3 morphant embryos also showed altered expression of genes 
involved in two conserved signaling pathways. Eight genes involved in Wnt signal-
ing were down-regulated and five genes of the Notch pathway showed up-regulated 
(4 genes) or down-regulated (1 gene) expression. Both signaling pathways play a 
role in early embryonal development. Wnt genes encode a large family of secreted 
glycoproteins that are involved in a wide spectrum of cell activities (Miller, 2002). 
Wnt receptor binding is tightly modulated through association with diverse secreted 
proteins, like  Dickkopf (Niehrs, 1999), Frzb-1 (Leyns et al., 1997; Wang et al., 1997) 
or Cerberus (Leyns et al., 1997), and through association with glycosaminoglycans. 
In addition to the essential role in embryonic patterning, the Wnt canonical pathway 
also plays a role in cell fate determination, and non-canonical Wnt signaling is re-
quired for regulation of planar cell polarity, cell adhesion, and motility (Katoh, 2008). 
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Wnt signaling also plays a role in T-cell development in the thymus. Using wnt1 
and wnt4 double knock-out mice it was shown that after 15-16 days of gestation the 
number of the thymocytes was reduced by 50-70% (Mulroy et al., 2002). The Notch 
signaling pathway, which was also affected in mzpl3 morphants, plays multiple roles 
in the development of the central nervous system including the regulation of neural 
stem cell (NSC) proliferation, survival, self-renewal and differentiation (Gaiano and 
Fishell, 2002; Lathia et al., 2008). Notch signaling also regulates keratinocyte prolif-
eration, and commitment and differentiation decisions in the skin (Blanpain et al., 
2006; Lee et al., 2007), and contributes to maintenance of the follicular structure of 
the hair (Demehri and Kopan, 2009). Furthermore, Notch signaling also activates T 
lineage differentiation from hemopoietic progenitors (Tydell et al., 2007) and has an 
important role in autoimmune disease through a non-canonical signaling pathway 
(Talora et al., 2008). The possible link of mpzl3 with Wnt and Notch signaling sug-
gested by our microarray data is of great interest for further investigation.
Conclusion
In this study we investigated the function of mpzl3 using overexpression and mor-
pholino knock-down analysis in zebrafish embryos. Taken together, the experimen-
tal data suggested that mpzl3 plays a role in developmental processes during early 
embryogenesis, which has not been previously reported in mammalians. The mzpl3 
mutation in rough coat mice is a hypomorphic mutation. A null mutant of mzpl3 
has not been described in mammalians, and based on the results of mpzl3 knock-
down in zebrafish might be embryonic lethal. Although the zebrafish study did not 
provide strong support for our previous hypothesis that mzpl3 may have an immune 
function (Racz et al, 2009), a link with the immune system was suggested by the lack 
of rag1 expression in mplz3 morphants. Furthermore, the motility defects in mplz3 
morphants might be related to defects in the formation or maintenance of myelin 
sheaths, which also requires the function of the closely related mpz gene. Our micro-
array analysis of mpzl3 morphants suggested alterations in Wnt and Notch signaling 
processes, which might underlie the observed developmental phenotypes. As Wnt 
and Notch signaling are also important for skin and nervous system development 
and immunological processes, the altered regulation of these pathways provides a 
useful lead for further investigations in the zebrafish and rough coat mouse models
Materials and Methods
Characterization of the zebrafish Mpzl3 protein:
The NCBI (http://www.ncbi.nlm.nih.gov/) and Ensembl (http://www.ensembl.
org/index.html) databases were used for gene structure and sequence analyses. For 
deriving the protein sequence the translate tool accessible on the ExPASy proteom-
ics server was used. Mpzl3 domain structure was identified with EBI-InterProScan 




By means of MART export using the Ensembl release 54 - May 2009 database 
(http://www.ensembl.org/biomart/index.html) all the PR00213 - PRINTS finger-
prints database records (Myelin_P0 domain) in zebrafish (Ensembl54 Danio rerio 
Zv8-dataset) were listed. The list was manually complemented with the Mpz, Mpzl1, 
and Mpzl3 protein sequences. The alignment and the phylogenetic tree were made 
using the ClustalW multiple sequence alignment program (http://www.ebi.ac.uk/
Tools/kalign/index.html) and the neighbor joining method.
Zebrafish strains and husbandry:
Zebrafish were handled in compliance with the local animal welfare regulations 
and maintained according to standard protocols (zfin.org). Experiments were per-
formed with ABxTL zebrafish and the fli:EGFP transgenic line was used to inves-
tigate the cardiovasculatory system of the morphant fish. Embryos were grown at 
28.5–30°C in egg water (60 µg/ml Instant Ocean sea salts). Embryos used for whole 
mount in situ staining were kept in egg water containing 0.003% 1-phenyl-2-thiourea 
(Sigma-Aldrich) to prevent melanization.
RNA isolation:
Embryos for RNA isolation were snap-frozen in liquid nitrogen and subsequently 
stored at -80°C. Embryos were homogenized in 1 ml of TRIzol reagent (Invitrogen), 
and subsequently total RNA was extracted according to the manufacturer’s instruc-
tions. The RNA samples were incubated for 20 min at 37°C with 10 U of DNaseI 
(Roche Applied Science) to remove residual genomic DNA before purification using 
the RNeasy MinElute Cleanup kit (Qiagen) according to the RNA clean-up pro-
tocol. Total RNA concentrations were determined spectrophotometrically using a 
Nanodrop ND-1000 (Isogen Life science). Optical density A260/A280 ratios of all 
samples ranged from 1.8– 1.9, indicating high purity.
Whole-mount in situ hybridization:
Embryos were fixed overnight in 4% paraformaldehyde in PBS at 4°C and whole-
mount in situ hybridization using alkaline phosphatase detection with BM purple 
substrate (Roche) was performed according to Thisse et al. (45). Total RNA was used 
to generate templates for riboprobes synthesis by PCR using mpzl3 gene-specific 
primers sets including the binding site for T7 RNA polymerase in the reverse primer: 
FW primer: 5’TGGTCTCCAGCAGAGGTCAGT3’, REV primer: 5’TAATACGACT
CACTATAGGGTGGTGTGTTCATGCAGTTTG3’. As a marker for the thymus we 
used recombination activating gene-1 (rag1): The sequences of the primers for rag1 




3’. Digoxigenin-labeled riboprobes were synthesized using the labeling mixes from 
Roche and Ambion MEGAscript reagents for in vitro transcription.
cDNA synthesis and quantitative real-time PCR:
cDNA synthesis reactions were performed in a 40μl mixture of 1000 µg of RNA, 8 
µl of 5x iScript reaction mix (Bio-Rad Laboratories), and 2 µl of iScript reverse tran-
scriptase (Bio-Rad Laboratories). The reaction mixtures were incubated at 25°C for 5 
min, 42°C for 30 min, and 85°C for 5 min. Real-time PCR was performed using the 
Chromo4 Real-time PCR detection system (Bio-Rad Laboratories) according to the 
manufacturer’s instructions. Each reaction was performed in a 25-µl volume com-
prised of 1 µl of cDNA, 12.5 µl of 2x iQ SYBR Green Supermix (Bio-Rad Laboratories), 
and 10 pmol of each primer. Cycling parameters were 95°C for 3 min to activate the 
polymerase, followed by 40 cycles of 95°C for 15 s and 60°C for 45 s. Fluorescence 
measurements were taken at the end of each cycle. Melting curve analysis was per-
formed to verify that no primer dimers were amplified. All reactions were performed 
as technical duplicates. For normalization, peptidylprolyl isomerase A-like ( ppial) was 
taken as reference (Stockhammer et al., 2009). Results were analyzed using the ΔΔCt 
method. Sequence of mpzl3 forward  primer: 5’GCTGCTGCTACTTCAAGGACTC3’ 
and mpzl3 reverse primer:  5’TGTGACTCTGTGATGGTGTGTTC3’.
Overexpression experiments:
Mpzl3 cDNA was cloned by RT-PCR on RNA from zebrafish embryos using the 
Superscript III one tube PCR system with Platinum taq (Invitrogen). Primers were 
designed to contain EcoRI and BamH1 restriction sites (FW:5’-CGGATCCTCACC
ATGTCGGTGTGGTCTCCAGCAGAGG-3’; REV: 5’-GGTGAATTCCTAACACT-
GTGACTCTGTGATGG-3’) for cloning into pCS2+ vector (http://sitemaker.umich.
edu/dlturner.vectors/home).  The pCS2+-mpzl3 construct was checked by sequenc-
ing performed by ServiceXS (Leiden, The Netherlands). To generate in vitro capped 
RNA for micro-injection the pCS2+-mpzl3 plasmid was digested with BamHI and 
EcoRI restriction endonuclease and used as a template for RNA synthesis using SP6 
polymerase according to the mMessage mMachine kit protocol (Ambion). Embryos 
at the 1 to 2 cell stage were injected with 1 nl containing 5 -75 pg mRNA.
Morpholino knock-down experiments:
Morpholino oligonucleotides (Gene Tools) were diluted to desired concentra-
tions in 1 Danieu’s buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM 
Ca(NO3)2, 5.0 mM HEPES (pH 7.6)) containing 1% phenol red (Sigma-Aldrich). To 
block translation of the mpzl3 mRNA, we injected between 0.1 mM (0.85 ng) and 
1 mM (8.4 ng) per embryo at the 1 to 2 cell stage. Morpholino sequences were: 5’-
CTGCTGGAGACCACACCGACATGC-3’ (MO1) and 5’-AACCCGGAAGTGAA-
GAAAACACACC-3’ (MO2). To control for aspecific morpholino effects, we used 
the standard control morpholino from Gene Tools. 
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Microscopy:
Images were taken using Leica M165C stereo and MZ16FA stereo fluorescence 
microscopes equipped with a DFC420C camera. Images were processed using Leica 
application suite (LAS) software.
Microarray analysis:
For microarray analysis embryos were injected at the 1-2 cell stage with 0.25 mM 
of MO1, 0.125 mM of MO2 or 0.25 mM of the standard control morpholino and 
RNA was isolated at 8 hpf. RNA (cRNA) was synthesized in one amplification round 
from 500ng of total RNA using the Agilent Two color Quick Amp kit. The dual-color 
hybridization of the microarray chips was performed according to Agilent protocol 
G4140-90050 version 5.7 (www.Agilent.com) for two-color microarray-based gene 
expression analysis. Labeled RNA from embryos injected with MO1 or MO2 was hy-
bridized against RNA from embryos injected with the standard control morpholino. 
The hybridizations were performed in duplicate with a dye swap. Microarray data 
were processed from raw data image files with Feature Extraction Software 9.5.3 
(Agilent Technologies). Processed data were subsequently imported into Rosetta 
Resolver 7.0 (Rosetta Biosoftware) and subjected to default ratio error modeling. The 
data were analyzed at the level of the individual probe sequences. Gene ontology 
(GO) analysis was performed using the GeneTools eGOn v2.0 web-based gene ontol-
ogy analysis software (www.genetools.microarray.ntnu.no).
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The rough coat mutation spontaneously developed in the C57BL/6J mouse strain 
and was identified in 1966 (Dickie, 1966) and mapped in 1977 at the 9th chromosome 
close to the Mpi-1 gene (Eicher and Reynolds, 1977). The next few decades the rough 
coat strain was not studied but in 2004 the laboratory of Dr. Csiszar focused on iden-
tifying the causative gene of the rough coat phenotype, as it was hypothesized that 
it might be allelic with Lysyl oxidase like gene (loxl), a matrix component. It turned 
out that rough coat is not allelic with loxl  (Hayashi et al., 2004) but the interest in 
the mutation remained. The main aim of my study described in this thesis was to 
answer two questions about the rough coat mutation: where is the exact location 
of the mutation in the mouse genome, and what kinds of mechanisms underlie the 
complex rough coat phenotype? To answer these questions we used forward and 
reverse genetic approaches, and investigated the mutation both by in vivo and in 
silico approaches.  
For identification of the mutation we first investigated in detail the phenotype of 
the rough coat mice and determined the phenotypic characteristics for the positional 
cloning analyses in Chapter 2.  The mutated mice developed cyclic and progressive 
hair loss by the weaning age and ulcers appeared on the ventral skin of the neck 
(63%) over the first year. Histological examination of the skin showed enlargement 
of the glands that secrete a waxy substance called sebum that functions to lubricate 
the skin and hair, and also showed excessive proliferation of the cells (sebocytes) 
involved in sebum production. Histological dissection of the ulcers revealed typical 
signs of chronic wounds. Previously the linkage of the rough coat locus (rc) with 
two microsatellite markers D9Mit162 at 49.954 Mb and D9Mit104 at 65.953 Mb was 
described (Hayashi et al., 2004). Using two different mice strains and published as 
well as novel polymorphic microsatellites we identified the mapping interval of the 
rc locus and by sequence analyses we identified a point mutation in the open reading 
frame within a novel gene (ENSMUSG00000070305) located at 44.989~45.009 Mb. 
The mutation is a G→A transition in exon 3 of this gene, resulting in an Arg100→Gln 
(R100Q) substitution. EST analyses revealed that at least two different transcripts ex-
ist in mice. One longer transcript consists of 6 exons and encodes a 237 amino acid 
polypeptide and the shorter one consists of 2 exons and encodes a 96 amino acid 
polypeptide. The protein was predicted as a cell adhesion molecule with the highest 
homology to Myelin Protein Zero (MPZ), Myelin Protein Zero-like 1 (MPZL1), and 
Myelin Protein Zero-like 2 (MPZL2, also called Epithelial V-like Antigen, EVA1). 
We therefore named this gene Mpzl3 (Myelin Protein Zero-like 3). All three proteins 
belong to a conserved protein family called Myelin Protein Zero. The major charac-
teristic of this family is that all the members have immunoglobulin V type and my-
elin P0 domains. We analyzed the expression pattern of Mpzl3 both at the transcript 
level using Reverse transcriptase-PCR and at the protein level using Western blot 
analysis. We found that Mpzl3 was expressed in all the investigated organs including 
brain, esophagus, heart, intestine, kidney, liver, lung, muscle, skin and spleen. Closer 
examination of the skin by immunofluorescence staining of skin sections using a 
Summary and General discussion
61
polyclonal antibody specific for extracellular domain of MPZL3 revealed that MPZL3 
is expressed in the keratinocytes in the epidermis, hair follicles, and sebocytes in the 
sebaceous glands. By examining staining at high magnifications, it was clear that the 
staining was strong around the plasma membrane, consistent with the prediction of 
a transmembrane protein involved in cell adhesion. We also detected staining in the 
cytoplasm, but not in the nuclei. 
To extend our knowledge of MPZL3, in Chapter 3 we addressed the question 
whether this protein exists only in mammals or is an older evolutionary conserved 
protein.  We were also interested in its domain structure and its possible role in hu-
man. Therefore, we analyzed the MPZL3 orthologue proteins in the available public 
databases and we investigated the sequence and domain structure with web based 
bioinformatics tools. We identified orthologues of MPZL3 in other mammals with 
79–99% identity at the protein level, and also found the protein to be conserved in 
other vertebrates, including chicken and zebrafish, with 30-55% amino acid identity. 
All the putative orthologue proteins possess the myelin P0 protein signature and 
immunoglobulin V-Type domain. Based on EST counts in the UniGene database 
of NCBI, MPZL3 is expressed in wide variety of organs in human. Similar to our 
expression data in mouse, MPZL3 expression was detected in human brain, esopha-
gus, heart, kidney, liver, lung, muscle, spleen, and in addition in blood, colon, eye, 
lymph node, mammary gland, mouth, ovary, parathyroid, pharynx, pituitary gland, 
prostate, stomach, testis, uterus and vascular tissues. Furthermore, EMBL-EBI Array 
Express microarray database analysis showed MPZL3 expression in dendritic cells, 
and in CD4 and CD8 central memory and effector T cells. The R100Q mutation 
we identified in rc mice is in the Ig-domain recognition loop that has known func-
tions in T-cell receptors and cell adhesion. The homologous MPZ and MPZL2/EVA1 
also play roles in cell adhesion and in the immune response. NCBI Entrez database 
analysis revealed multiple SNPs and mutations within the MPZL3 gene suggesting 
that humans with homozygous or compound heterozygous mutations may devel-
op symptoms similar to the anomalies observed in rc mice. To investigate whether 
MPZL3 has a similar expression pattern in the skin as we observed in mice we per-
formed Western blot analysis and detected a 54 kDa and a fainter 56 kDa band in cul-
tured primary human dermal fibroblasts, which may result from dimerization and/
or from posttranslational modifications of MPZL3 (predicted MW 25.98 kDa). Using 
indirect immunofluorescence we localized MPZL3 in similar regions of the human 
skin as in the mouse skin (Cao et al., 2007). It can be hypothesized that, based on our 
in silico data, MPZL3 might be involved in immune-mediated hereditary disorders 
presenting with hair loss, like alopecia area or alopecia universalis.
As the rough coat point mutation in Mpzl3 already has strong effects, it is pos-
sible that the complete lack of Mpzl3 function may lead to more drastic changes in 
the affected organ systems and result in a lethal phenotype in mice. Considering the 
time investment and the possible outcome of the mouse knock-out experiment, in 
Chapter 4 we decided first to investigate the mpzl3 gene function in the zebrafish 
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embryo model, in which rapid knock-down studies are possible. First we investi-
gated the zebrafish mpzl3 sequence in the public databases, and analyzed the domain 
structure of the predicted protein with EBI-InterProScan web based software. We 
identified its evolutionary related counterparts by phylogenetic analysis using the 
neighbor joining method and found that closely related genes in zebrafish included 
mpz, mpzl1, eva1, and scn4b. By using quantitative reverse transcriptase PCR (qRT-
PCR) we observed high mpzl3 expression in the embryos within the first 5 hours 
post fertilization, likely derived from maternal RNA, but at later time points mpzl3 
expression became gradually reduced. We analyzed the localization of mpzl3 expres-
sion by whole mount in situ hybridization and recognized specific expression in the 
head and in neuromasts of the lateral line of larvae at 5 days post fertilization. To in-
vestigate the role of mpzl3 in zebrafish we synthesized mpzl3 mRNA and injected this 
into embryos at the 1-2 cell stage. We observed a general retardation of development, 
bent and shortened tails or edema of the heart cavity in some embryos, but we also 
observed consistent anophthalmia. Some embryos showed aberrant development of 
both eyes and others showed asymmetric development of the two eyes, with one de-
veloping normally and the other being highly abnormal or completely undeveloped. 
Based on this unexpected phenotype, we decided to investigate the phenotype of the 
eye in rough coat mouse and we observed clear eye abnormalities in the mutant too 
(Figure1). Homozygous rough coat mice have been noted to be prone to develop an 
eye phenotype that could described in lay terms as “cloudy”, or as a whitish haze. It 
may affect one eye, sometimes both eyes. It has not been investigated whether these 
mice are able to see with those affected eyes. The onset has not been seen before four 
months.  
To analyze the effect of mplz3 knock-down on development of zebrafish we used 
translation blocking morpholinos. The morphant fish obtained with two different 
morpholinos showed lower survival rates, immobility in response to touch stimuli, 
and cardiovascular system defects. They also showed a deficiency in the expression 
of recombination activating gene 1 (rag1) in the thymus, a gene essential for the de-
velopment of the adaptive immune system. The morphant phenotypes could be res-
cued by co-injection of mpzl3 mRNA. To identify the molecular pathways underly-
ing the mpzl3 morphant phenotype we performed a preliminary microarray analysis 
to analyze the gene expression pattern changes at 8 hours post fertilization, prior to 
the appearance of the phenotypic abnormalities. Based on gene ontology term analy-
sis of the overlapping gene set showing altered expression with both morpholinos 
we identified several genes that play a role in developmental processes, including 
components of the Wnt and Notch signaling pathways. These microarray data pro-
vide useful leads for further investigation of mpzl3 function in zebrafish and mouse 
models. 
In conclusion, in this study the gene responsible for the rough coat phenotype 
in mouse was identified and shown to encode a member of the Myelin Protein Zero 
family that we named Mpzl3. The hypomorphic mutation in the rough coat mice was 
Summary and General discussion
63
shown to be due to an amino acid substitution in the conserved immunoglobulin 
domain of Mpzl3 and resulted in severe skin abnormalities. We argue that mutations 
in the human orthologue of Mpzl3 may be involved in immune-mediated heriditary 
hair loss diseases. Furthermore, we identified the mpzl3 gene in zebrafish and we 
present here the first functional study of this gene. Our overexpression and loss-of-
function experiments indicated a role for mpzl3 in developmental processes during 
zebrafish embryogenesis, which based on microarray analysis might involve Wnt 
and Notch signaling. In future work, it will be of great interest to study the con-
nection of mpzl3 with these signaling pathways and the possible role of the gene in 
skin development, myelination and immune functions using zebrafish and mouse 
models
Figure 1. Eye phenotypes of rough coat mice. Figure (A) shows a 6 months old rc/rc male mouse 
with affected eyes. In Figure (B) and (C) it can be observed that both eyes are affected; however, 
the appearance of the abnormalities is different. Figure (D) and (E) shows the cloudiness of the 
eyes. Figure (F) shows a 6 months old rc/+ control male littermate.
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Samenvatting
Het zogenoemde “rough coat”-fenotype (rc) van de muis is ontstaan door een 
spontane mutatie in de veelgebruikte laboratoriumstam C57BL/6J. De mutatie werd 
in 1966 ontdekt (Dickie, 1966) en in 1977 gelokaliseerd op chromosoom 9 (Eicher 
and Reynolds, 1977). In 2004 richtte de groep van Dr. Csiszar zich op de identificatie 
van het gen dat verantwoordelijk is voor het rc-fenotype. Aanvankelijk hadden zij de 
hypothese dat het gemuteerde gen een allel zou zijn van het loxl-gen (Lysyl oxidase 
like), dat codeert voor een component van de extracellulaire matrix (Hayashi et al., 
2004). Het bleek echter dat rc onafhankelijk was van loxl. Hierna bleef de interesse in 
de identificatie van de rc-mutatie bestaan. Het belangrijkste doel van het onderzoek 
beschreven in dit proefschrift was het beantwoorden van twee vragen rond the rc-
mutatie: wat is de exacte locatie van de mutatie in het genoom van de muis en welke 
mechanismen liggen ten grondslag aan het complexe rc-fenotype? Om deze vragen 
te beantwoorden hebben wij verschillende genetische strategieën gebruikt om het 
gemuteerde gen te identificeren en de functie ervan te onderzoeken. Hierbij hebben 
gebruik gemaakt van twee modelorganismen, de muis en de zebravis. Naast de “in 
vivo”-experimenten in deze modelorganismen werden tevens “in silico”-studies uit-
gevoerd om de functie van het overeenkomstige gen in de mens te voorspellen.
Om de rc-mutatie te identificeren hebben wij eerst in detail het fenotype van de 
“rough coat”-muizen onderzocht en de kenmerken vastgesteld op grond waarvan de 
positionele klonering van het gemuteerde gen kon worden uitgevoerd. Dit onder-
zoek is beschreven in hoofdstuk 2. Jonge muizen met de rc-mutatie ontwikkelden 
een cyclische en progressieve haaruitval en gedurende het eerste jaar ontstonden er 
bij 63% van de dieren zweren op de huid aan de onderzijde van de nek. Histologisch 
onderzoek van de huid liet zien dat er een vergroting was van de klieren die een 
vettige substantie (sebum) uitscheiden dat dient om de huid en het haar te smeren. 
Tevens was het aantal cellen dat betrokken is bij de sebum-productie (sebocyten) 
sterk verhoogd. De zweren in de huid vertoonden typische kenmerken van chro-
nische wonden. Eerder was beschreven dat het rc-locus genetisch is gekoppeld met 
twee microsatelliet-markers, D9Mit162 op 49.954 Mb en D9Mit104 op 65.953 Mb 
(Hayashi et al., 2004). Door gebruik te maken van twee verschillende muizenstam-
men en gepubliceerde zowel als nieuwe microsatelliet-polymorfismen konden we 
de chromosomale positie van het rc-locus in kaart brengen. Vervolgens werd door 
sequentieanalyse een puntmutatie gevonden in de coderende regio van een nieuw 
gen (ENSMUSG00000070305) gelegen op 44.989~45.009 Mb. De mutatie is een 
G→A-transitie in exon 3 van dit gen, resulterend in een Arg100→Gln-substitutie 
(R100Q). Uit databaseanalyses bleek dat er in de muis minstens twee verschillende 
transcripten bestaan van dit gen. Het langste transcript bestaat uit 6 exonen en co-
deert voor een polypeptide van 237 aminozuren, terwijl het kortere transcript uit 2 
exonen bestaat en codeert voor een polypeptide van 96 aminozuren. De voorspelde 
functie van het eiwit is dat het een celadhesiemolecuul betreft, homoloog met Myelin 
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Protein Zero (MPZ), Myelin Protein Zero-like 1 (MPZL1) en Myelin Protein Zero-
like 2 (MPZL2, ook bekend als EVA1 voor Epithelial V-like Antigen 1). Wij hebben 
het nieuwe gen daarom Mpzl3 (Myelin Protein Zero-like 3) genoemd. MPZ, MPZL1, 
MPZL2 en MPZL3 behoren allevier tot een geconserveerde eiwitfamilie, genaamd 
Myelin Protein Zero. Het belangrijkste kenmerk van deze eiwitfamilie is dat alle leden 
V-type-immunoglobulinedomeinen en myeline-P0-domeinen bevatten. Wij hebben 
het expressiepatroon van Mpzl3 geanalyseerd zowel op transcriptniveau door middel 
van reverse-transcriptase-PCR als op eiwitniveau door middel van Western-blot-
analyse. Hieruit bleek dat Mpzl3 tot expressie komt in alle onderzochte weefsels en 
organen, waaronder de hersenen, de slokdarm, de darm, de nier, de lever, de milt, het 
hart, de longen, het spierweefsel en de huid. Coupes van huidweefsel werden nader 
onderzocht door middel van immunofluorescentie-analyse met een polyclonaal an-
tilichaam specifiek voor het extracellulaire domein van het MPZL3-eiwit. Hiermee 
kon het MPZL3-eiwit aangetoond worden in de keratinocyten van de huidepidermis, 
in de haarwortels en in de sebocyten van de sebum-producerende klieren. Bij hoge 
vergroting was te zien dat de kleuring het sterkste was rond de plasmamembraan 
van de cellen. Dit is in overeenstemming met de voorspelde functie van het eiwit als 
een transmembraaneiwit betrokken bij celadhesie. Er was ook kleuring in het cyto-
plasma aantoonbaar, maar niet in de celkern.
Om meer kennis te vergaren over MPZL3 hebben wij in hoofdstuk 3 de vraag 
onderzocht of het eiwit alleen in zoogdieren bestaat of dat het een ouder, evolution-
air geconserveerd eiwit betreft. Ook waren wij geïnteresseerd in de domeinstructuur 
van het eiwit en de mogelijke functie in de mens. Daarom hebben wij de beschikbare 
publieke databasen doorzocht om homologe eiwitten te identificeren en hebben we-
bgebaseerde bioinformaticasoftware toegepast om de domeinstructuur te analyseren. 
In andere zoogdieren vonden wij eiwitten die op aminozuurniveau 89-96% identiek 
waren aan MPZL3 van de muis. Ook vonden wij het eiwit in andere gewervelde dier-
soorten, waaronder de zebravis en de kip, met 30 % identiteit op aminozuurniveau. 
Alle voorspelde orthologe eiwitten van MPZL3 bevatten de myeline-P0-signatuur 
en de V-type-immunoglobulinedomeinen. Gebaseerd op transcriptsequenties in de 
UniGene-database van het NCBI komt het humane MPZL3-gen tot expressie in di-
verse organen van de mens. In overeenstemming met onze expressiedata van de muis, 
zijn humane MPZL3-transcripten aantoonbaar in hersenen, slokdarm, hart, nier, le-
ver, long, spier en milt. Tevens is er expressie gedetecteerd in bloed en vaatweefsel, 
in oog, mond en keelholte en het maagdarmkanaal, in lymfeklieren, melkklieren, 
bijschildklier en hypofyse, en in prostaat en testis, alsmede uterus en ovarium. Uit 
analyse van de microarray-databank van het EMBL-EBI bleek tevens dat MPZL3 
tot expressie komt in dendritische cellen van het humane immuunsysteem, evenals 
in CD4- en CD8-positieve geheugen-  en effector-T-cellen. De R100Q-mutatie die 
wij geïdentificeerd hadden in de “rough coat”-muizen is gelokaliseerd in een regio 
(“recognition loop”) van het immunoglobulinedomein met bekende functies in 
T-cell receptoren en bij celadhesie. De homologe MPZ- en MPZL2/EVA1-eiwitten 
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spelen ook een rol in celadhesie en in de immuunrespons. Bij analyse van de NCBI-
database werden verschillende nucleotide-polymorfismen en mutaties in het humane 
MPZL3-gen gevonden, wat erop zou kunnen wijzen dat mensen met homozygote of 
samengestelde heterozygote mutaties symptomen zouden kunnen ontwikkelen die 
lijken op de afwijkingen in muizen met de rc-mutatie. Om te onderzoeken of het 
humane MPZL3-gen een vergelijkbaar expressiepatroon vertoont in de huid als het 
overeenkomstige gen in de muis hebben wij een Western-blot-analyse uitgevoerd. In 
extracten van gekweekte humane huidcellen (een cultuur van primaire fibroblasten) 
kon een eiwitband met een grootte van 54 kDa aangetoond worden en een zwakkere 
band van 56 kDa. Deze banden kunnen het resultaat zijn van dimeervorming en/of 
van post-translationele modificatie van MPZL3, dat een molecuulgewicht heeft van 
25.98 kDa.  Met behulp van indirecte immunofluorescentie konden wij het MPZL3-
eiwit lokaliseren in vergelijkbare regionen van de humane huid als in de huid van 
de muis (Cao et al., 2007). Op grond van onze in silico-studie kan de hypothese 
gemaakt worden dat MPZL3 betrokken zou kunnen zijn bij immuun-gemedieerde 
erfelijke afwijkingen die gepaard gaan met haaruitval, zoals de ziekten alopecia area 
of alopecia universalis.
Omdat de rc-puntmutatie in Mpzl3 al ernstige effecten heeft, is het waarschijnlijk 
dat een volledig verlies van de functie van dit gen (knock-out) zou kunnen leiden tot 
nog ernstiger afwijkingen en tot een letaal fenotype in de muis. Gezien de tijdsinves-
tering en de mogelijke uitkomst van een knock-out-experiment in de muis, hebben 
wij in hoofdstuk 4 besloten om eerst de functie van het mpzl3-gen te bestuderen in 
het zebravisembryomodel, waarin snelle knock-down-studies mogelijk zijn. Eerst 
hebben wij de sequentie van het mpzl3-gen van de zebravis onderzocht in de pub-
lieke databases en de domeinstructuur van het gecodeerde eiwit geanalyseerd met 
het webgebaseerde programma EBI-InterProScan. Door middel van fylogenetische 
analyse met de “neighbor joining”-methode hebben wij de evolutionaire verwant-
schappen van mpzl3 met andere genen in het zebravisgenoom bepaald, waaruit bleek 
dat mpz, mpzl1, eva1 en scn4b het meest nauw verwant zijn aan mpzl3. Met behulp 
van kwantitatieve reverse-transcriptase-PCR (qRT-PCR) kon een hoge expressie van 
mpzl3 in embryo’s worden aangetoond binnen de eerste 5 uur na fertilisatie (waarsch-
ijnlijk afkomstig van maternaal RNA), maar tijdens latere ontwikkelingsstadia nam 
het expressieniveau van mpzl3 geleidelijk af. Vervolgens hebben wij het expressie-
patroon van mpzl3 verder geanalyseerd door middel van in situ-hybridisatie van 
zebravisembryo’s en -larven. Hierbij werd specifieke expressie waargenomen in de 
kop en in de neuromastcellen van het zijlijnorgaan van zebravislarven op de leeftijd 
van 5 dagen. Om de rol van mpzl3 tijdens de zebravisontwikkeling te onderzoeken 
hebben wij mpzl3-mRNA gesynthetiseerd en dit geïnjecteerd in embryo’s van het 
1- tot 2-celstadium. Wij observeerden een algemene vertraging van de ontwikkeling 
en een gebogen en verkorte staart of hartoedeem in sommige embryo’s. Echter, het 
meest opvallende en consistente fenotype was de afwezigheid van ogen (anophthal-
mia). Sommige embryo’s vertoonden een afwijkende ontwikkeling van beide ogen en 
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bij andere ondergingen de ogen een asymmetrische ontwikkeling, waarbij één oog 
zich normaal ontwikkelde terwijl het andere sterk misvormd of volledig onderon-
twikkeld was. Vanwege dit onverwachte fenotype besloten wij om het fenotype van 
de ogen van de muizen met de rc-mutatie te inspecteren en vonden hier ook duideli-
jke oogafwijkingen. Homozygote rc-muizen ontwikkelen vaak een oogfenotype dat 
in lekentermen omschreven zou kunnen worden als troebel of als een witachtige 
waas over het oog. Soms is één oog aangedaan en soms beide. Het is nog niet onder-
zocht of de muizen zicht hebben in deze ogen. De aandoening treedt niet eerder op 
dan na vier maanden.
Om het effect van uitschakeling van de mpzl3-genfunctie op de ontwikkeling 
van zebravisembryo’s te onderzoeken hebben wij gebruikt gemaakt van morfolino’s, 
waarmee specifiek de translatie van het mpzl3-mRNA geblokkeerd kan worden 
(knock-down-techniek). De knock-down-embryo’s verkregen met twee verschil-
lende morfolino’s vertoonden een verminderde overleving, waren immobiel in reac-
tie op een aanrakingsstimulus en vertoonden afwijkingen in het hart- en vaatstelsel. 
Tevens vertoonden deze embryo’s een deficiëntie in de expressie van het rag1-gen 
(recombination activating gene 1, een essentieel gen voor het immuunsysteem) in de 
thymus. Als controle-experiment kon het knock-down-fenotype opgeheven worden 
door mpzl3-mRNA te injecteren samen met de morfolino. Om inzicht te krijgen in 
de moleculaire processen die ten grondslag liggen aan het knock-down-fenotype 
van mpzl3 hebben wij een preliminaire microarrayanalyse uitgevoerd om de veran-
deringen in het genexpressiepatroon te onderzoeken op 8 uur na fertilisatie, een 
tijdspunt vóór de zichtbaarheid van de fenotypische afwijkingen. De set van genen 
die veranderde expressie vertoonde bij beide morfolino’s bevatte verschillende genen 
die een rol spelen bij ontwikkelingsprocessen, waaronder componenten van de Wnt- 
en Notch-signaalroutes. Deze microarraydata hebben bruikbare aanknopingspunten 
opgeleverd voor verder onderzoek naar de functie van mpzl3 in de zebravis- en muis-
modelsystemen.
Samenvattend heeft deze studie geleid tot de identificatie van het gen dat verant-
woordelijk is voor het “rough coat”-fenotype in de muis en heeft aangetoond dat dit 
gen codeert voor een eiwit van de Myelin Protein Zero-familie, dat wij MPZL3 ge-
noemd hebben. De hypomorfe mutatie in de “rough coat”-muizen bleek veroorzaakt 
te zijn door een aminozuursubstitutie in het geconserveerde immunoglobulinedo-
mein van MPZL3 en resulteerde in verschillende huidafwijkingen. Wij betogen dat 
mutaties in de humane ortholoog van MPZL3 betrokken kunnen zijn bij immuun-
gemedieerde erfelijke ziekten die gepaard gaan met haaruitval. Daarnaast hebben 
wij het mpzl3-gen in zebravis aangetoond en beschrijven hier de eerste functionele 
studie van dit gen. Onze overexpressie- en knock-down-experimenten wijzen op 
een rol voor mpzl3 bij ontwikkelingsprocessen tijdens de zebravisembryogenese, 
waarbij, gebaseerd op microarrayanalyse, de Wnt- en Notch signaalroutes mogelijk 
betrokken zijn. In toekomstige studies zal het zeer interessant zijn om het verband 
tussen mpzl3 en deze signaalroutes verder te onderzoeken en om de rol van het gen 
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bij huidontwikkeling, bij de vorming van myelinescheden en bij het immuunsysteem 
verder te ontrafelen met gebruik van zebravis- en muis-modellen.

Összefoglalás
A C57BL/6J egértörzsben spontán mutációval keletkezett, ún. rough coat (rc) 
egereket 1966- ban a Main állambeli JAX laboratóriumban azonosították, majd a 
mutációt 1977-ben a 9-es kromoszómára térképezték közel az Mpi1-es génhez. Az 
ezt követő évtizedekben a mutáns törzs tudományos érdeklődés perifériájára került 
egészen 2004-ig, amikor is Prof. Dr. Csiszár Katalin a lysyl oxidase (lox) vizsgálata 
során célul tűzte ki, hogy azonosítja a rough coat fenotípus kóroki génjét, ami al-
lélikus lehet a lox-al. Bár a két gén között allélizmus nem volt kimutatható, a tu-
dományos kíváncsiság a rough coat törzzsel kapcsolatban továbbra is fennmaradt. E 
disszertációban olvasható tanulmánynak a célja, hogy azonosítsa a rough coat egerek 
megjelenésének genotipikus hátterét, valamint, hogy a mutáción keresztül ment gén 
molekuláris funkciójára fényt derítsen.
A tanulmány 2. fejezetének az elején azokat a fenotipikus jegyeket határoztuk 
meg, melyeket a pozícionális klónozás során követni kívántunk, majd a fejezet 
további részében a mutáció azonosításának lépéseit tárgyaltuk. A mutáns egerekre 
autoszómális recesszív öröklésmenet jellemző. Születéskor a mutáns egyedeket 
alomtársaiktól megkülönböztetni nem lehet, de az elválasztási korban már jól meg-
mutatkozik a nevet is adó,  borzolt szőrzettel jellemzhető szőrhullásos fenotípus, mely 
az idő múlásával progresszivitást mutat. Ultrastruktúrális vizsgálatok megmutatták, 
hogy a szőrhullás hátterében nem a szőrszáll megváltozott struktúrája áll, hanem 
feltételezhetően a szőr növekedési ciklusában bekövetkezett molekuláris változás. A 
bőr szerkezetének hisztopatológás analízise során hypertrophikus faggyúmirigy sej-
teket azonosítottunk, melyekre a vad típusú alomtársaikkal összehasonlítva erőteljes 
faggyútermelés volt a jellemző. Mindemellett az egerek szignifikáns há nyadánál 
(63%) egy éves kor után spontán seb megjelenését tapasztaltuk a ventrális nyaki 
ol dalon. A seb szövettani metszetén epidermális hiperpláziát, alatta a dermiszben 
pedig krónikus aktív inflaminációt figyelhetünk meg. Előzetes vizsgálatok az rc 
lókusz pozícióját a D9Mit162 marker (49.954 Mb) és a D9Mit104 (65.953 Mb) között 
azonosították. Két különböző egértörzs, már leírt és újonan felfedezett mikroszate-
lita markerek, valamint szekvencia analízis segítségével egy pontmutációt azonosí-
tottunk egy eddig ismeretlen génen belül (ENSMUSG00000070305) 44.989~45.009 
Mb között, mely feltételezhetően felelőssé tehető a mutáns fenotípus kialakításáért. 
A mutáció a gén 3- as exonjában egy G→A tranzíciót okoz, mely fehérjeszinten egy 
Arg100→Gln cserét eredményez. A gén EST analízise rávilágított, hogy a gén le-
galább 2 db transzkripttel rendelkezik egérben. Egy 6 exonból álló hosszabb transz-
kripttel, ami mintegy 237 aminosav hosszúságú polipeptid láncot kódol, valamint egy 
rövidebb, 2 exonból álló transzkripttel, ami 96 aminosavból álló láncolatot kódol. A 
fehérje aminosav sorrendje alapján a Myelin P0 fehérje család Myelin Protein Zero 
(MPZ) és Myelin Protein Zero-like 2 (MPZL2, Epithelial V-like Antigen) fehérjéi-
vel mutatott nagyfokú homológiát, ezért mi a rough coat egerekben azonosított új, 
mind idáig ismeretlen gént Mpzl3 (Myelin Protein Zero-like 3) génnek neveztük el. A 
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gén expressziós vizsgálata kimutatta, hogy a géntermék számos helyen kifejeződik az 
egérben, úgymint az agyban, a belekben, a bőrben, az izomban, a lépben, a májban, 
a nyelőcsőben, a szívben, a tüdőben és a vesében. A bőr és függelékeinek közelebbi 
tanulmányozása poliklonális antitesttel kimutatta, hogy az MPZL3 a keratinociták, a 
szőrtüsző, és a faggyúmirigy sejtjeinek a palzmamembránjában lokalizálható. 
Azért, hogy az Mpzl3 természetét és funkcióját minél jobban megismerjük a 3. 
fejezetben in silico vizsgálatokat végeztünk el az Mpzl3 nukleotid és fehérje szekven-
ciáját alapul véve. Kiváncsiak voltunk, vajon a fehérje csak az emlősőkben található-e 
meg, vagy már az evolúció korábban megjelent szervezeti formáiban is kifejeződik. 
Mindemellett vizsgálni kívántuk az MPZL3 domain szerkezetét a fehérje humán or-
tológjának az esetében, azzal a céllal, hogy esetlegesen a szekvencia, valamint szerkezeti 
vizsgálatok az egér fenotipikus megjelenésével kiegészítve választ nyújthatnak a gén 
mutációjának humán patológiás kondíciójának a kifejeződésére is. Vizsgálataink ki-
mutatták, hogy a fehérje először a gerinces szervezetekben jelent meg. A fehérje szek-
venciája emlősökben 79–99% azonosságot mutat. Mindegyik vizsgált ortológ fehérje 
a Myelin P0 fehérjecsaládba tartozott, és rendelkezett Immunoglobulin V típusú do-
mainnel. Az USA Biotechnológia Információs Központjának (NCBI) UniGene adat-
bázisának EST analízise alapján humán szervezetben a gén - egér szervezetben ta-
pasztaltakhoz hasonlóan - számtalan helyen mutat kifejeződést. Ezenfelül munkánk 
során vizsgáltuk a gén expresszivitását EMBL-EBI Array Express microarray adatbázis 
alapján. Eredményeink azt mutatták, hogy  a gén az immunrendszer felépítésében is 
szerepet játszó  dentrikus sejtekben, valamint a CD4 és CD8 sejtekben is kifejeződik. 
A fehérje 3D homológián alapuló analízise kimutatta, hogy az egérben tapasztalható 
Arg100→Gln mutáció az immunoglobulin V típusú domén extracelluláris oldalán 
található, és mint ilyen a prediktált adhéziós funkciót könnyen befolyásolhatja. A 
homológ fehérjék vizsgálata megmutatta, hogy Mpzl3 homológ fehérjéi a Myelin P0 
(Mpz), valamint a Myelin Protein Like 2 (Mpzl2), vagy más néven az Epithelial-V-like 
antigen (Eva1) fehérjék szintén rendelkeznek adhéziós funkcióval, valamint jelentős 
szerepük van az immunrendszer működésében is. Azért, hogy megvizsgáljuk vajon a 
humán szervezetben a fehérje hasonló megjelenést mutat-e, mint az egérben, embri-
onális humán fibroblaszt sejttenyészet felhasználásával Western blot analízist végez-
tünk, valamint az egér poliklonális antitestjének felhasználásával humán metszeten 
immunhisztokémiai szövetfestést csináltunk. Az emberi bőrből származó szöveti 
vizsgálataink kimutatták, hogy MPZL3 egy 54 kDa és egy 56 kDa nagyságú fehér-
jét kódol humánban, ami egy dimerizációnak, vagy posztranszlációs módosítás nak 
lehet az eredménye. Immunhisztokémiai vizsgálatainkban egérhez hasonlóan a ke-
ratinociták és a szőrtüszők plazmamembránjában lévő kifejeződését tapasztaltuk. Az 
eddigi eredményeket figyelembe véve a 3. fejezetben leírt eredmények alapján azt 
feltételeztük, hogy a fehérje szerepet játszhat emberben az immunrendszernek hibás 
működésének következtében kialakuló szőrhullásos folyamatokban, mint amilyen az 
Alopecia számtalan formája.
Bár az Mpzl3 in silico analízise a gén funkcióját olyan adhéziós fehérjeként predik-
Összefoglalás 
77
tálta, aminek szerepe lehet immunmediált szőrhullásos folyamatokban, mint amilyen 
az alopecia, a gén funkcionális annotációja nem történt meg. A disszertáció 4. feje-
zetében funkciónyeréses  és antiszensz morpholino knock down technikát alkalmaz-
va kísérletet tettünk az mpzl3 okozta komplex fenotípus hátterének a felderítésére 
zebrahalban. Mindenekelőtt bioinformatikai adatbázisokban szereplő adatok alap-
ján vizsgáltuk az mpzl3 genom szekvenciáját, majd EBI InterProScan software segít-
ségével meghatároztuk annak doménstruktúráját, és a legközelebbi szomszéd mód-
szerével (neighbour joining method) azonosítottuk a Myelin P0 fehérjecsaládhoz 
tartozó többi fehérjéhez fűződő evolúciós kapcsolatait. Evolúciós értelemben vett 
legközelebbi fehérjék a mpz, a mpzl1, az eva1 és a scn4b. Annak érdekében, hogy az 
in silico adatokat megerősítsük, qRT-PCR és in situ hibridizáció segítségével meg-
határoztuk az mpzl3 expresszióját a fejlődő zebrahal embriókban. Vizsgáltaink magas 
mpzl3 expressziós szintet mutattak már a megtermékenyítést követően, ami a gén-
expresszió anyai hatásának lehetséges következménye. Késöbbi időpontba vett min-
tákon az mpzl3 RNS szintjének a csökkkenését tapasztaltuk. In situ hibridizáció során 
a gén korai expresszióját figyeltük meg a halak oldalvonalának az érzékelősejteiben 
(neuromast-ban), a kloákában, a kopoltyúívekben, valamint az úszóhólyagban. Azért, 
hogy meghatározhassuk az mpzl3 funkcióját, szintetikus mpzl3 RNS-t készítettünk 
és 1-2 sejtes állapotban bejuttattuk a fejlődő zebrahal embriókba. A megnövekedett 
mpzl3 szint hatására a halakra általános retardáció, a faroknyúlvány megrövidült mi-
volta, a szívburok hypertrophiája és veleszületett, anophthalmia volt a jellemző.  Az 
embriók egy részénél  mindkét szem teljes vagy részleges hiányát figyelhettük meg, 
míg másoknál csak az egyik szem fejlődése volt rendellenes, míg a másik normális 
fejlődést mutatott. Annak érdekébe, hogy az mpzl3 funkciójáról teljes képet kaphas-
sunk, antiszensz morfolino  knockdown technika segítségével vizsgáltuk a lecsökkent 
mpzl3 szint hatását a fejlődő zebrahal embriókra. A morfolinóval kezelt halakra meg-
növekedett letalitás, általános retardáció, az esetek 30 %-ban teljes mozgásképtelen-
ség, valamint kardio-vaszkuláris elváltozások, úgymint hypertrophikus szívburok, és 
az érfal szerkezeti változásai voltak a jellemzőek. In silico adatok alapján feltételeztük, 
hogy az mpzl3 által kódolt fehérje szerepet játszik a csecsemőmirigy és a T sejtek 
érésében, ezért a morphant halak csecsemőmirigy specifikus génjének, a recombina-
tion activating gene-1-nek (rag1) a kifejeződését vizsgáltuk. Megállapítottuk, hogy 
a morphant halakban nem fejeződik ki a rag1 gén, ami a csecsemőmirigy fejlődési 
és funkcionális működésének a hiányosságára utal. Annak érdekében, hogy meg-
határozzuk a morphant halakban megjelenő transzkriptómikai változásokat, micro-
array analízist végeztünk el egyedi tervezésű 4x44 k mikrochipen. Mikrochip vizs-
gálataink a knockdown mpzl3 morfolino embriókban az egyedfejlődésben fontos 
jelátviteli útvonalak olyan elemeinek megváltozott expresszióját azonosították, mint 
a Notch vagy a Wnt. 
Összefoglalásképpen elmondhatjuk, hogy ebben a tanulmányban mikroszatelita 
markerek segítségével azonosítottuk a rough coat (rc) egértörzsben előforduló gene-
tikai mutációt egy eddig ismeretlen génben, amit mi a Myelin P0 fehérjecsaládhoz, 
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és legfőképpen a Myelin Protein Zero Like 2 (Mpzl2) fűződő nagyfokú szekvencia 
homológia miatt, Myelin Protein Zero Like 3 (Mpzl3)-nak neveztünk el. Az oko-
zott fenotípus egy Arg-Glu szubsztitúció következménye a fehérje konzervált funk-
cionális régiójában. In silico technikák alkalmazásával vizsgáltuk eme fehérjének 
a meglétét, és expressziós mintázatát ember esetében is. Vizsgálataink alapján azt 
feltételeztük, hogy az említett fehérje szerepet játszhat az immunrendszer működé-
sének rendelleneségeivel összefüggő szőrhullásos folyamatokban is, mint amilyen az 
alopécia. Hogy a gén funkcionális hátterét in vivio módon is tanulmányozni tudjuk, 
azonosítottuk az egér mpzl3 ortológját zebrahalban, és a génre specifikus szinteti-
kus RNS molekula és antiszensz morpholino oligonukleotid felhasználásával funk-
ciónyeréses és funkcióvesztéses kísérletet végeztünk el. Vizsgálataink megmutatták, 
hogy az Mpzl3 számtalan fejlődési folyamatban szerepet játszik, aminek a hátterében 
mikrochip vizsgálat alapján a Wnt és a Notch szignalizációs útvonalak megváltozott 
működése állhat. Úgy gondoljuk, hogy a jövőben az Mpzl3 kapcsolata a fent emlí-
tett szignalizációs útvonalakkal hozzájárulhat a bőr, az immunrendszer, valamint a 
demyelinizációs folyamatok a pontosabb megértéséhez.
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